>P27980|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus agm.vervet (isolate AGM3)|Swiss-Prot MGAATSALNRRQLDKFEHIRLRPTGKKKYQIKHLIWAGKEMERFGLHERLLESEEGCKKI IEVLYPLEPTGSEGLKSLFNLVCVLFCVHKDKEVKDTEEAVAIVRQCCHLVEKERNAERN TTETSSGQKKNDKGVTVPPGGSQNFPAQQQGNAWIHVPLSPRTLNAWVKAVEEKKFGAEI VPMFQALSEGCTPYDINQMLNVLGDHQGALQIVKEIINEEAAQWDIAHPPPAGPLPAGQL RDPRGSDIAGTTSTVQEQLEWIYTANPRVDVGAIYRRWIILGLQKCVKMYNPVSVLDIRQ GPKEAFKDYVDRFYKAIRAEQASGEVKQWMTESLLIQNANPDCKVILKGLGMHPTLEEML TACQGVGGPSYKAKVMAEMMQNMQSQNMMQQGGQRGRPRPPVKCYNCGKFGHMQRQCPEP RKMRCLKCGKPGHLAKDCRGQVNFFRVWPVDGSETQKFSRRYSWGGANCAPSTESIRPCK EAPAAICRQGEAVEGTKEKTTSSESRLDRGIFFELPLWRRPIKTVYIEGVPIRALLDTGA DDTIIKEADLQLSGTWKPKIIGGIGGGLNVKEYSDREVRLEDKILRGTILIGSTPINIIG RNILAPAGAKLVMGQLSEQIPITPVKLKEGARGPFLKQWPLSKEKIKALQEICDQLEKEG KISKIGGENAYNTPVFCIKKKDKSQWRMLVDFRELNKATQDFFEVQLGIPHPSGFEKMTE ITVLDIGDAYYSIPLDPEFRKYTAFTIPSVNNQGPGTRYQFNCLPQGWKGSPTIFQNTAA SILEEIKKELKPLTIVQYMDDLWVGSQEDEYTHDRLVEQLRMKLSAWGLETPDKKVQKKP PYEWMGYKLWPHKWQISSIELEDKEEWTVNDIQRLVGKLNWAAQLYPGLRTKNLCKLIRG KKNLLETVTWTEEAEAEYAENKEILKTEQEGTYYKPGRPIRAAVQKLEGGQWSYQFKQEG QVLKVGKYTKQKNTHTNEFRVLAGLVQKLCKESLVIWGELPVLELPIEREVWEQWWADYW QVSWIPDWEFVSTPPLVKLWYTLTKEPIPKEDVYYVDGACNRNSREGKAGYITQYGKQRV EKLENTTNQQAELMAIKMALEDSGPNVNIVTDSQYAMGILTAQPTQSDSPLIEQIIALMV QKHQIYLQWVPADKGIGGNEEIDKLVSQGMRKILFLEKIEEAQEEHERYHNNWRNLADTY GLPQIVAKEIVAMCPKCQIKGEPVHGQVDASPGVWQMDCTHLEGKVIIVAVHVASGFIEA EVIPRETGKETAKFLLKILSRWPITQLHTDNGPNFTSQEVAAMCWWGKIEHTTGVPYNPQ SQGSIESMNKQLKEIIGKIRDDCQYTETAVLMACHIHNFKRKGGIGGLTPAERLINMITT QLELQHLQTKIQKILNFRVYYREGRDPVWKGPGQLIWKGEGAVVIKGGVELKEYPRRKAK IIKDYEPRKRMGDESNLEGAGGADN >P05895|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus agm.vervet (isolate AGM TYO-1)|Swiss-Prot MGAATSALNRRQLDKFEHIRLRPTGKKKYQIKHLIWAGKEMERFGLHERLLESEEGCKKI IEVLYPLEPTGSEGLKSLFNLVCVLFCVHKDKEVKDTEEAVAIVRQCCHLVEKERNAERN TTETSSGQKKNDKGVTVPPGGSQNFPAQQQGNAWIHVPLSPRTLNAWVKAVEEKKFGAEI VPMFQALSEGCTPYDINQMLNVLGDHQGALQIVKEIINEEAAQWDIAHPPPAGPLPAGQL RDPRGSDIAGTTSTVQEQLEWIYTANPRVDVGAIYRRWIILGLQKCVKMYNPVSVLDIRQ GPKEAFKDYVDRFYKAIRAEQASGEVKQWMTESLLIQNANPDCKVILKGLGMHPTLEEML TACQGVGGPSYKAKVMAEMMQNMQSQNMMQQGGQRGRPRPPVKCYNCGKFGHMQRQCPEP RKMRCLKCGKPGHLAKDCRGQVNFFRVWTVDGGKTEKFSRRYSWSGTECASSTERHHPIR PSKEAPAAICRERETTEGAKEESTGNESGLDRGIFFELPLWRRPIKTVYIEGVPIKALLD TGADDTIIKENDLQLSGPWRPKIIGGIGGGLNVKEYNDREVKIEDKILRGTILLGATPIN IIGRNLLAPAVPRLVMGQLSEKIPVTPVKLKEGARGPCVRQWPLSKEKIEALQEICSQLE QEGKISRVGGENAYNTPIFCIKKKDKSQWRMLVDFRELNKATQDFFEVQLGIPHPAGLRK MRQITVLDVGDAYYSIPLDPNFRKYTAFTIPTVNNQGPGIRYQFNCLPQGWKGSPTIFQN TAASILEEIKRNLPALTIVQYMDDLWVGSQENEHTHDKLVEQLRTKLQAWGLETPEKKMQ KEPPYEWMGYKLWPHKWELSRIQLEEKDEWTVNDIQKLVGKLNWAAQLYPGLKTRICKLI TGGKKNLLELVAWTPEAEAEYAENAEILKTEQEGTYYKPGIPIRAAVQKLEGGQWSYQFK QEGQVLKVGKYTKQKNTHTNELRTLAGLVQKICKEALVIWGILPVLELPIEREVWEQWWA DYWQVSWIPEWDFVSTPPLLKLWYTLTKEPIPKEDVYYVGACNRNSKEGKAGYISQYGKQ RVETLENTTNQQAKLTAIKMALEDSGPNVNIVTDSQYAMGILTAQPTQSDSPLVEQIIAL MIQKQQIYLQWVPAHKGIGGNEEIDKLVSKGIRRVLFLEKIEEAQEKHERYHNNWKNLAD TYGLPQIVAKEIVAMCPKCQIKGEPVHGQVDASPGTWQMDCTHLEKKVVIVAVHVASGFI EAEVIPRETGKETAKFLLKILSRWPITQLHTDNGPNFTSQEVAAICWWGKIEHTTGIPYN PQSQGSIESMNKQLKEIIGKIRDDCQYTEAAVLMACILHNFKRKGGIGGQTSAERLINII TTQLEIQHLQTKIQKILNFRVYYREGRDPVWKGPAQLIWKGEGAVVLKDGSDLKVVPRRK AKIIKDYEPKQRVGNEGDVEGTRGSDN >Q82851|retroviral ribonuclease H|EC 3.1.26.13|Jembrana disease virus|Swiss-Prot MKLSKLEKALKKVRVTPQRDDTYTIGNVLWAIRMCRLMGLDCCIDEATAAEVAILIGRFQ SLDLQDSPLKGKDEKAILTTLKVLWSLLAGHHPENSDMAEKYWEAWTIRERESQKEEEGE ITSIYPQLRKNFPAVSTSDGSPRYDPDLTKQLKIWADATEKHGVDHHAVNILGVITANLT QSEIRLLLQSTPQWRLDIQLIESKLNAREHAHRVWKESHPEAPKTDEIIGKGLTAAEQAT LTTQECRDTYRQWVLEAALEVAQGKHDRPGPINIHQGPKEPYPEFVNKLVTALEGMAAPE TTKQYLLDHLSVDHANEDCRAVLLPLGPSAPMERKLEACRAVGSSKQKMQFLAEAFAAIN VKGDGEVQRCYGCGKPGHIRRDCKNQKCFKCGKPGHLQRNCKSKNREALLCPFWAEERIP SGEDFCDPVCSPVGIRLNRQPFIKIFLGGRWVRALIDTGADEVVLKDIHWDRIKGVPAAS VVQVGVTGRNIARRKSNVEWRFKNRYGIVDVLFSNTPVNLLGRSVLQSIVTKFTLAAHTK QIQPLPVKLHGPGPRVPQWPLTLEKYKALKEIVEELLKDGKISRTPWDNPFNTPVFVIKK KGGSKWRMLMDFRALNKVTNKGQEFQIGLPYPPGIQQCEHITAIDIKDAYFTIPLDENFR QYTAFSVVPVNREGPLERYHWNVLPQGWVCSPAIYQTTTQEIIAEIKDRFPDIVLYQYMD DLLIGSDRPDHKRVVSEIREELGAYGFKTPEEKIQEEQVQWLGYELTPKRWRFQPRQIKI KKVVTVNELQQMIGNCVWVQPEVKIPLSPLSDLLKGKTDLKDKIKLTEEAIQCLETVNKR LKDPEWKERIKEGTELVVKIQLIPEGVVYDLLQDGNPIWGGVKGWDYNHANKIKKMLSIM KKLSRIVMIMTGREVSFLIPGDSEDWESALQRINTLTEIPEVKFYKHACRWTSVCGPVIE RYPTYYTDGGKKGSKAAAAYWREGKIRREVFPGTNQQAELKAVLMALQDGPAKMNIITDS RYAFEGMREEPETWGREGLWKEIGEELRRKEYVGVSWVPGHKGIGGNTEVDQEVQKALQG PITVSLPQEILLEAGETKLVKTGIFWEGLRPCKLRPEEGLKLKGSLIDEELQLEITNTQN SRVGIRQGQTIGTCFIEAIPQAIEEHEKWHTTAEILAREFQLPRRVAREIVHRCQACKRT VSCPRRGTNPRERFLWQMDNTHLEGKIIWVAVETNSGLIEARVIPEESAQSIVFCILMLV YRYTVYHIHSDNGPCFIAQKVEALCKYLKITKTTGIPYNPQAQAIVERTHRDIKDKIAAF REDCETVEAALSLTLVALNKKRGGIGGHTPYEIYLESEYNKYQEQQNHYNNFKTEKWAYV RDKRKVWKGPYKVLWDGEGAAVVEENAMPTLYPHRHMRFIPPPNTDTQDGNL >P16901|retroviral ribonuclease H|EC 3.1.26.13|Ovine maedi visna related virus (strain South Africa)|Swiss-Prot SNITAGKQQEGATCGAVRAPYVVTEAPPKIDIKVGTNWKKVLVDTGADRTIVRYHDNSGI PTGRIKLQGIGGIIEGEKWDKVVIQYKEKRIEGTIVVLPSSPVEVLGRDNMAKLDIGIIM ANLEEKKIPITQVKLKEGCKGPHIAQWPLTQEKLEGLKEIVDKLEKEGKVGRAPPHWTCN TPIFCIKKKSGKWRMLIDFRELNKQTEDLAEAQLGLPHPGGLQKKKHVTILDIGDAYFTI PLYEPYRPYTCFTMLSPNNLGPCTRYYWKVLPQGWKLSPSVYQFTMQEILRDWIAKHPMI QFGIYMDDIYIGSDLDIMKHREIVEELASYIAQYGFMLPEEKRQEGYPAKWLGFELHPEK WRFQKHTLPEIKEGTITLNKLQKLVGDLVWRQSLIGKSIPNILKLMEGDRALQSERRIEL RHVKEWEECRRKLAEMEGNYYDEEKDVYGQIDWGDKAIEYIVFQERGKPLWVNVVHNIKN LSQSQQIIKAAQKLTQEVIIRIGKIPWILLPGKEEDWILELQIGNITWMPSFWSCYRGSI RWKKRNVITEVVEGPTYYTDGGKKNGKGSLGFIASTGVKFRKHEEGTNQQLELRAIEEAC KQGPEKMNIVTDSRYAYEFMRRNWDEEVIKNPIQARIMKLVHDKEQIGVHWVPGHKGIPQ NEEIDKYISEIFLAREGSGILPKRAEDAGYDLICPQEVCIPAGQVRKIPINLRINLKEDQ WAMVGTKSSFASKGVFVQGGIIDSGYQGIIQVVVYNSNDKEVIIPQGRKFAQLILMPLIH EDLEAWGETRRTERGNQGFGSTGAYWIENIPLAEEDHSKWHQDAGSLHLDFGIPRTAAED IVQQCEVCQENKMPSTIRGSNRRGIDHWQVDYTHYEDKIILVWVETNSGLIYAERVKGET GQEFRIMTIRWYGLFAPKSLQSDNGPAFVAEPTQLLMKYLGITHTTGIPWNPQSQALVER THQTLKNTIEKFVSMFASFDSAIAAALITLNIKRKGGLGTSPMDIFIFNKEQQRIQQQST RNQSKFRFCYYRVRKRGHPGEWLGPTQVLWEGEGAIVIKDKNLEKYLVIAKKDVKFIPQP KEIQTE >P19560|retroviral ribonuclease H|EC 3.1.26.13|Bovine immunodeficiency virus (strain R29)|Swiss-Prot MKRRELEKKLRKVRVTPQQDKYYTIGNLQWAIRMINLMGIKCVCDEECSAAEVALIITQF SALDLENSPIRGKEEVAIKNTLKVFWSLLAGYKPESTETALGYWEAFTYREREARADKEG EIKSIYPSLTQNTQNKKQTSNQTNTQSLPAITTQDGTPRFDPDLMKQLKIWSDATERNGV DLHAVNILGVITANLVQEEIKLLLNSTPKWRLDVQLIESKVREKENAHRTWKQHHPEAPK TDEIIGKGLSSAEQATLISVECRETFRQWVLQAAMEVAQAKHATPGPINIHQGPKEPYTD FINRLVAALEGMAAPETTKEYLLQHLSIDHANEDCQSILRPLGPNTPMEKKLEACRVVGS QKSKMQFLVAAMKEMGIQSPIPAVLPHTPEAYASQTSGPEDGRRCYGCGKTGHLKRNCKQ QKCYHCGKPGHQARNCRSKNREVLLCPLWAEEPTTEQFSPEQHEFCDPICTPSYIRLDKQ PFIKVFIGGRWVKGLVDTGADEVVLKNIHWDRIKGYPGTPIKQIGVNGVNVAKRKTHVEW RFKDKTGIIDVLFSDTPVNLFGRSLLRSIVTCFTLLVHTEKIEPLPVKVRGPGPKVPQWP LTKEKYQALKEIVKDLLAEGKISEAAWDNPYNTPVFVIKKKGTGRWRMLMDFRELNKITV KGQEFSTGLPYPPGIKECEHLTAIDIKDAYFTIPLHEDFRPFTAFSVVPVNREGPIERFQ WNVLPQGWVCSPAIYQTTTQKIIENIKKSHPDVMLYQYMDDLLIGSNRDDHKQIVQEIRD KLGSYGFKTPDEKVQEERVKWIGFELTPKKWRFQPRQLKIKNPLTVNELQQLVGNCVWVQ PEVKIPLYPLTDLLRDKTNLQEKIQLTPEAIKCVEEFNLKLKDPEWKDRIREGAELVIKI QMVPRGIVFDLLQDGNPIWGGVKGLNYDHSNKIKKILRTMNELNRTVVIMTGREASFLLP GSSEDWEAALQKEESLTQIFPVKFYRHSCRWTSICGPVRENLTTYYTDGGKKGKTAAAVY WCEGRTKSKVFPGTNQQAELKAICMALLDGPPKMNIITDSRYAYEGMREEPETWAREGIW LEIAKILPFKQYVGVGWVPAHKGIGGNTEADEGVKKALEQMAPCSPPEAILLKPGEKQNL ETGIYMQGLRPQSFLPRADLPVAITGTMVDSELQLQLLNIGTEHIRIQKDEVFMTCFLEN IPSATEDHERWHTSPDILVRQFHLPKRIAKEIVARCQECKRTTTSPVRGTNPRGRFLWQM DNTHWNKTIIWVAVETNSGLVEAQVIPEETALQVALCILQLIQRYTVLHLHSDNGPCFTA HRIENLCKYLGITKTTGIPYNPQSQGVVERAHRDLKDRLAAYQGDCETVEAALSLALVSL NKKRGGIGGHTPYEIYLESEHTKYQDQLEQQFSKQKIEKWCYVRNRRKEWKGPYKVLWDG DGAAVIEEEGKTALYPHRHMRFIPPPDSDIQDGSS >P17283|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate CPZ GAB1)|Swiss-Prot MGARASVLTGGKLDRWEKVRLRPGGRKRYMMKHLVWASRELERFAKRHHGEQQSKTESNS GSREGGASQGASASAGISGNYPLVQNAQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPM FSALSEGALPQDVNTMLNAVGGHQGAMQVLKEVINEEAAEWDRLHPTHAGPIAPGQLREP RGSDIAGTTSTLQEQIGWTTANPPIPVGDVYRRWVILGLNKVVRMYCPVSILDIRQGPKE PFRDYVDRFYKTLRAEQASQEVKNWMTDTLLVQNANPDCKQILKALGPGATLEEMMTACQ GVGGPSHKARVLAEAMSMVQNQGRADVFFQKGQGAGPKRKIKCFNCGKEGHLARNCKAPR RKGCWRCGQEGHQMKDCTGRQVNFFRERLAFPQREARQLCAEQNRTNGPTDRELWVPGGR EEPGEERGREQSISTNLPQITLWQRPLIPVKVEGQLCEALLDTGADDTVIERIQLQGLWK PKMIGGIGGFIKVKQFDNVHIEIEGRKVVGTVLVGPTPVNIIGRNILTQLGCTLVFPISS IETVPVKLKPGMDGPKVKQWPLSAEKIKALTEICQEMEKEGKISKIGPENPYNTPIFAIK KKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSCPLDKDF RKYTAFTIPSINNETPGVRYQYNVLPQGWKGSPSIFQSSMTKILEPFREKNPDITIYQYM DDLYVGSDLEIDQHRKKVEELRQHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPI QLPEKEVWTVNDIQKLIGKLNWASQIYPGIKIKQLCKLIRGTKKLTDVVPLTPEAELELA ENREIVSTPVHGVYYDPDKELIAEIQKQGNCQWTYQIFQEPHKNLKTGKYARQRSAHTND IRQLAEAVQKIATESIVIWGKTPKFRLPVQKESWEAWWAEYWQATWIPEWEFINTPPLVK LWYSLETEPIPTTDTYYVDGAANRETKTGKAGYVTDKGKQKIISLENTTNQQAELKALLL ALQDSDQQVNIVTDSQYVLGIIQSQPDHSESELVNQIIEELIKKEKIYLSWVPAHKGIGG NEQVDKLVSAGIRKVLFLDGIDRAQEEHERYHSNWKAMASDFNLPPIVAKEIVAHCDKCQ VKGEAMHGQVDCSPGIWQVDCTHLEGKVIIVAVHVASGYIEAEVIPAETGQETAYFLLKL AGRWPVKTIHTDNGPNFTSAAVKAACWWADIKQEFGIPYNPQSQGVVESLNKELKKIIGQ VRDQAEHLKTAVQMAVFIHNFKRKGGIGGYTAGERIIDIIATDIQTSELQKQILKVQKFR VYYRDSRDPIWKGPATLLWKGEGAVVIQDQGELKVVPRRKAKIIRDYGKQMAGDDCVASR QNED >Q1A249|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate EK505)|Swiss-Prot MGARASVLTGGKLDQWEKIYLRPGGKKKYMMKHLVWASRELERFACNPGLMDTAEGCAQL LRQLEPALKTGSEGLRSLFNTLAVLYCVHNNIKVQNTQEALEKLREKMKAEQKEPEPEQA AGAAAAPESSISRNYPLVQNAQGQMVHQPLSPRTLNAWVKVVEEKAFNPEVIPMFMALSE GATPQDLNTMLNTVGGHQAAMQMLKEVINEEAAEWDRGHPVHMGPIPPGQVREPRGSDIA GTTSTLAEQVAWMTANPPVPVGDIYRRWIVLGLNKIVRMYSPASILDIKQGPKETFRDYV DRFYKTLRAEQATQEVKNWMTETLLVQNANPDCKNILRALGPGASLEEMMTACQGVGGPA HKARVLAEAMTQAQTATSVFMQRGNFKGIRKTIKCFNCGKEGHLARNCKAPRKKGCWKCG QEGHQMKDCRSGERQFFREGLASLQREARKFPPDNNKERANSPSNRELWVSGGEDHTGDR EGRKGEDRELSVPTLNFPQITLWQRPILTVKIGGEIKEALLDTGADDTVIEEIQLEGKWK PKMIGGIGGFIKVKQYDNVIIEIQGKKAVGTVLVGPTPVNIIGRNFLTQIGCTLNFPISP IETIPVKLKPGMDGPRVKQWPLTEEKIKALTEICTEMEKEGKISRIGPENPYNTPIFAIK KKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSCPLDENF RKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSTMTKILEPFRKNNPELVIYQYM DDLYVGSDLEITQHREAVERLRSHLLTWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQTI QLPEKDTWTVNDIQQLVGKLNWASQIYPGIKVKQLCKLIRGAKALTEVVTLTREAELELA ENREILKEPVHGAYYNPDKELIAEIQKQGQGQWTYQIYQDLHKNLKTGKYAKMRSTHTND IRQLTEVVQKVALESIVIWGKTPKFRLPVQKEVWETWWTEYWQATWIPDWEFVNTPPLVK LWYQLETEPISGAETYYVDGAANRETKLGKAGFVTDRGRQKVTSISETTNQQAELQAVLM ALQDAGQEVNIVTDSQYVLGIIHSQPDKSESELVNQIIEELIKKERIYLSWVPAHKGIGG NEQIDKLVSTGIRKVLFLDGIDKAQEEHERYHSNWKAMASDFNLPPIVAKEIVASCDKCQ LKGEAIHGQINCSPGVWQLDCTHLEGKIILVAVHVASGYLEAEVIPAETGQETAYFILKL AGRWPVKVIHTDNGSNFTSATVKAACWWANIQQEFGIPYNPQSQGAVESMNKELKKIIGQ IRDQAEHLKTAVQMAVFIHNFKRKGGIGGYTAGERIIDIIATDIQTTKLQTQILKVQNFR VYYRDSREPTWKGPAKLLWKGEGAVVIQDNGDIKVVPRRKAKIIRDYGKQMAGDGCVASG QDESQDME >Q02836|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus agm.grivet (isolate AGM gr-1)|Swiss-Prot MGGGHSALSGRSLDTFEKIRLRPNGKKKYQIKHLIWAGKEMERFGLHEKLLETKEGCQKI IEVLTPLEPTGSEGLKALFNLCCVIWCIHAEQKVKDTEEAVVTVKQHYHLVDKNEKAAKK KNETTAPPGGESRNYPVVNQNNAWVHQPLSPRTLNAWVKCVEEKRWGAEVVPMFQALSEG CLSYDVNQMLNVIGDHQGALQILKEVINEEAAEWDRTHRPPAGPLPAGQLRDPTGSDIAG TTSSIQEQIEWTFNANPRIDVGAQYRKWVILGLQKVVQMYNPQKVLDIRQGPKEPFQDYV DRFYKALRAEQAPQDVKNWMTQTLLIQNANPDCKLILKGLGMNPTLEEMLIACQGVGGPQ HKAKLMVEMMSNGQNMVQVGPQKKGPRGPLKCFNCGKFGHMQRECKAPRQIKCFKCGKIG HMAKDCKNGQANFFRVWPLGRSETKKFCAIQRRHSWSGTNSPPNGNSLRSSKEAPPAVCR EGTAPERGERTDKETEGERSGGCFLELPLWRRPMKRVIIEGTPVQALLDTGADDTIIQEK DLHFPPHKPWRSKVVGGIGGGIHVKEYQGVQVQLEDKIITGSILIGSTPINIIGRNILAQ AGMKLVMGVLSSQIEETKVQLKEGKDGPKLKQWPLSREKIEALTEICKQMEEEGKLSRIG GENPYNTPVFAIKKKDKTQWRMLVDFRELNKATQDFFEVQLGIPHPAGLQKKKQITVIDI GDAYYSIPLCKEFRKYTAFTIPSVNNTGPGIRYQFNCLPQGWKGSPTIFQNTAANILEEI KRHTPGLEIVQYMDDLWLASDHDETRHNQQVDIVRKMLLEKGLETPDKKVQREPPWEWMG YKLHPNKWTINKIELPPLEGEWTVNKIQKVVGVLNWASQIYPGIKTKHTCAMLRGKKNLL EEIVWTEEAEAEYKNNQGIVQETQEGTYYDPLKELIATVQKQGEGQWTYQFTQEGAVLKV GRYAKQRETHTNDLRTLAHLVQKICKEALTIWGRLPRVQLPVDKKTWDMWWQDYWQVSWI PEWEFVSTPLLVKLWYSLVKEPIKGEDVYYVDGAASKVTKLGKAGYLSERGKSRIRELEN TTNQQAELTAVKMALEDSGENVNIVTDSQYVMNILTACPQESNSPLVEQIIQALMKKRQV YLQWVPAHKGIGGNTEIDKLVSKGIRQILFLDRIEEAQDDHAKYHNNWRSMVQEFGLPNI VAKEIVAACPKCQIRGEPKHGQVDASIETWQMDCTHLEGKVIIVAVHVASGFIEAEVIPR ETGKETAHFLLKLLARWPVKHLHTDNGPNFTSQNVAAVCWWGNIEHTTGIPYNPQSQGSV ESMNRQLKEIISQIRDDCERLETAVQMATHIHNFKRKGGIGGISSAERLVNMLTTQLELN TLQNQIQKILNFKVYYREGRDPVWKGPARLIWKGEGAVVIKEGEDIKVVPRRKAKIIKDY GERKTMDSEGSMEGVREANKQMEGDSDLQDQE >P22382|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate GB1)|Swiss-Prot MGNGNSALLGTDLDKFEKIRLKRGGKKCYRLKHLCWCKGELDRFGLSDKLLETQQGCEKI LSVCWPLYDQGSDNLKALVGTVCVVACIHAGIEIKSTQDALKKLKVITRKEEKQEDESKN FPVQRDAAGQYQYTPISPRIIQTWVKTVEEKKWKPEVIPLFSALTEGAISHDLNIMLNAV GDHQGAMQVLKDVINEQAAEWDLTHPQQQPAQPGGGLRTPSGSDIAGTTSTVEEQLAWMN MQQNAINVGTIYKSWIILGMNRLVKSHCPISITDVRQGPKEAFKDYVDRFYNVMRAEQAS GEVKMWMQQHLLIENANPECKQILRSLGKGATLEEMLEACQGVGGPQHKARLMAEMMRTV VGQSQNFVQQRGPQRGPVRQPTGRKPICFNCNKEGHVARFFKAPRRKGCWNCGAMDHQKA QCPKPAQQQRVNFFRVWPLGSLQTGELSGTRGDSNSSTIRGETSAENSEHLSEIRERAQA EDEGGEERGGFSFPEYSLSRRPIEEVSVDGVTIRALLDTGADDTIFNERNIKLKGNWQPK IIGGIGGNLRVKQYDNVYVEIRGKGTFGTVLIGPTPIDIIGRNIMEKLGGKLILAQLSDK IPITKVKLKPGVDGPRIKQWPLSKEKIVGLQKICDRLEEEGKISRVDPGNNYNTPIFAIK KKDKNEWRKLIDFRELNKLTQDFHELQLGIPHPAGIKKCKRITVLDIGDAYFSIPLDPDY RPYTAFTVPSVNNQAPGKRYMYNVLPQGWKGSPCIFQGTVASLLEVFRKNHPTVQLYQYM DDLFVGSDYTAEEHEKAIVELRALLMTWNLETPEKKYQKEPPFHWMGYELHPDKWKIEKV QLPELAEQPTVNEIQKLVGKLNWAAQLYPGIKTKQLCKLIRGGLNITEKVTMTEEARLEY EQNKEILAEEQEGSYYDPNKELYVRFQKTTGGDISFQWKQGNKVLRAGKYGKQKTAHSND LMKLAGATQKVGRESIVIWGFVPKMQIPTTREIWEDWWHEYWQCTWIPEVEFISTPMLER EWYSLSPEPLEGVETYYVDGAANRDSKMGKAGYITDRGFQRVEEYLNTTNQQTELHAVKL ALEDSGSYVNIVTDSQYVVGILASRPTETDHPIVKEIIELMKGKEKIYLSWLPAHKGIGG NEQIDKLVSSGIRKVLFLQNIEPAQEEHEKYHSNEAQLREKFHLPALVAKQIVQSCSKCC HHGEPIKGQTDASLGVWQIDCTHLENQIIIVAVHVASGFMKAEVITAETGKKTAEFLLKL AAQWPISKLHTDNGPNFTSQEVETMCWWLGIEHTFGIPYNPQSQGVVENKNKYLKELIEK IREDCKELKTAVAMATFIHNFKQRGGLGGMTAGERIVNMINTELEYQYQQNQISKNLNFK VYFREGRDQLWKGPGILLWKGEGAVVLKYQEEIKIVPRRKCKIIKDYGESGKNSQVNLES V >P05896|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate Mm142-83)|Swiss-Prot MGARNSVLSGKKADELEKIRLRPGGKKKYMLKHVVWAANELDRFGLAESLLENKEGCQKI LSVLAPLVPTGSENLKSLYNTVCVIWCIHAEEKVKHTEEAKQIVQRHLVMETGTAETMPK TSRPTAPFSGRGGNYPVQQIGGNYTHLPLSPRTLNAWVKLIEEKKFGAEVVSGFQALSEG CLPYDINQMLNCVGDHQAAMQIIRDIINEEAADWDLQHPQQAPQQGQLREPSGSDIAGTT STVEEQIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTNILDVKQGPKEPFQSYVDR FYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGTNPTLEEMLTACQGVGGPGQK ARLMAEALKEALAPAPIPFAAAQQKGPRKPIKCWNCGKEGHSARQCRAPRRQGCWKCGKM DHVMAKCPNRQAGFFRPWPLGKEAPQFPHGSSASGADANCSPRRTSCGSAKELHALGQAA ERKQREALQGGDRGFAAPQFSLWRRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYT PKIVGGIGGFINTKEYKNVEIEVLGKRIKGTIMTGDTPINIFGRNLLTALGMSLNLPIAK VEPVKSPLKPGKDGPKLKQWPLSKEKIVALREICEKMEKDGQLEEAPPTNPYNTPTFAIK KKDKNKWRMLIDFRELNRVTQDFTEVQLGIPHPAGLAKRKRITVLDIGDAYFSIPLDEEF RQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRHVLEPFRKANPDVTLVQYM DDILIASDRTDLEHDRVVLQLKELLNSIGFSSPEEKFQKDPPFQWMGYELWPTKWKLQKI ELPQRETWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTLTEEVQWTEMAEAEYE ENKIILSQEQEGCYYQESKPLEATVIKSQDNQWSYKIHQEDKILKVGKFAKIKNTHTNGV RLLAHVIQKIGKEAIVIWGQVPKFHLPVEKDVWEQWWTDYWQVTWIPEWDFISTPPLVRL VFNLVKDPIEGEETYYVDGSCSKQSKEGKAGYITDRGKDKVKVLEQTTNQQAELEAFLMA LTDSGPKANIIVDSQYVMGIITGCPTESESRLVNQIIEEMIKKTEIYVAWVPAHKGIGGN QEIDHLVSQGIRQVLFLEKIEPAQEEHSKYHSNIKELVFKFGLPRLVAKQIVDTCDKCHQ KGEAIHGQVNSDLGTWQMDCTHLEGKIVIVAVHVASGFIEAEVIPQETGRQTALFLLKLA SRWPITHLHTDNGANFASQEVKMVAWWAGIEHTFGVPYNPQSQGVVEAMNHHLKNQIDRI REQANSVETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQEIQFQQSKNSKFKNFRV YYREGRDQLWKGPGELLWKGEGAVILKVGTDIKVVPRRKAKIIKDYGGGKEMDSSSHMED TGEAREVA >Q1A267|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate MB66)|Swiss-Prot MGARASVLTGGKLDRWEKIYLRPGGKKKYMMKHLVWASRELERFACNPSLMETTEGCKQL LQQLEPALKTGSEGLRSLFNTIVVLWCVHQGIPVKDTKEALDQLQEAQQKGKQEVAAATA DGTSTVSRNFPIVANAQGQMVHQPISPRTLNAWVKVVEEKAFSPEVIPMFMALSEGATPQ DLNTMLNTVGGHQAAMQMLKEVINEEAAEWDRLHPVHAGPVPPGQMREPRGSDIAGTTST IQEQVGWMTSNPPIPVGDIYKRWIILGLNKIVKMYCPVSILDIKQGPKESFRDYVDRFYK TLRAEQATQEVKNWMTDTLLVQNANPDCKSILRALGPGATLEGDEPAFQGVGGPSHKARV LAEAMSQAQHSNDAKRQFKGPKRIVKCFNCGKEGHIARNCKAPRRKGCWKCGQEGHQMRN CTNERQANFFRETLAFQQGKAREFPSEETRTNSSTNRELRVQGGGTCPEGGSEERGDREQ AVSSANFPQISLWQRPVVTVRIEGQLKEALLDTGADDTVLEEIELGGRWKPKMIGGIGGF IKVRQYDNVTIDICGKRAVGTVLVGPTPVNIIGRNILTQIGCTLNFPISPIETVPVSLKP GMDGPRVKQWPLTEEKIRALTEICTEMEKEGKISRVGPENPYNTPIFAIKKKDSTKWRKL VDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSCPLDENFRKYTAFTIPS VNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEIIIYQYMDDLYVGSDLK IELHREKVEELRAHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKESWTV NDIQKLIGKLNWACQIYPGIRVKQLCKLIRGTKALTEVVTFTTEAELELAENREILKEPV HGAYYDPSKELIAEIQKQGQGQWTYQIFQEQYKNLKTGKYARMRSAHTNDVKQLTEVVQK VALESIVIWGKVPRFRLPIQKETWEAWWTDYWQATWIPEWEYVNTPPLVKLWYQLEQDPI PGAETFYVDGAANRETKLGKAGYVTDKGRQKIISLTETTNQKAELQAIQLALQDSEVEVN IVTDSQYALGIIQGQPDTSESEIVNQIIEELIKKEKVYLSWVPAHKGIGGNEQIDKLVSS GIRKVLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPIVAKEIVANCDKCQLKGEAIHGQV DCSPGIWQLDCTHLEGKIILVAVHVASGYMEAEVIPAETGQETAYFILKLAGRWPVKVIH TDNGSNFTSSTVKAACWWAGIQQEFGIPYNPQSQGVVESMNKELKKIIGQIRDQAEHLKT AVQMAVFIHNFKRKGGIGGYSAGERIIDILATDIQTTKLQQQISNIQKFRVYYRDSRDPI WKGPAKLLWKGEGAVVLQDQEEIKVVPRRKAKIIRDYGKQMAGDDCVASRQDENQNME >P05897|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate K6W)|Swiss-Prot MGARNSVLSGKKADELEKIRLRPGGKKKYMLKHVVWAANELDRFGLAESLLENKEGCQKI LSVLAPLVPTGSENLKSLYNTVCVIWCIHAEEKVKHTEEAKQIVQRHLVVETGTAETMPK TSRPTAPSSGRGGNYPVQQIGGNYVHLPLSPRTLNAWVKLIEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIRDIINEEAADWDLQHPQPAPQQGQLREPSGSDIAGTT SSVDEQIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTNILDVKQGPKEPFQSYVDR FYKSLRAEQTDAAVKNWMTQTLLIQNANPDCKLVLKGLGVNPTLEEMLTACQGVGGPGQK ARLMAEALKEALAPVPIPFAAAQKRGPRKPIKCWNCGKEGHSARQCRAPRRQGCWKCGKM DHVMAKCPDRQAGFFRPWSMGKEAPQFPHGSSASGADANCSPRGPSCGSAKELHAVGQAA ERKQREALQGGDRGFAAPQFSLWRRPVVTAHIEGQPVEVLLDTGADDSIVTGIELGPHYT PKIVGGIGGFINTKEYKNVEIEVLGKRIKRTIMTGDTPINIFGRNLLTALGMSLNLPIAK VEPVKVALKPGKVGPKLKQWPLSKEKIVALREICEKMEKDGQLEEAPPTNPYNTPTFAIK KKDKNKWRMLIHFRELNRVTQELYRSPIRIPHPAGLAKRKRITVLDIGDAYFSIPLDEEF RQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRHVLEPFRKANPDVTLVQYM DDILIASDRTDLEHDRVVLQLKELLNSIGFSTPEEKFQKDPPFQWMGYELWPTKWKLQKI ELPQRETWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTLTEAVQWTEMAEAEYE ENNIILSQEQEGCYYQEGKPLEATVIKSQDNQWTYKIHQEDKILKVRKFAKIKNTHTNGV RLLAHVIQKIGKEAIVIVGQVPKFHLPVERDVWEQWWTDYWQVTWIPEWDFISTPPLVRL VFNLVKDPIEVEETYYTDGSCNKQSKEGKAGYITDRGKDIVKVLTTTNQQAELEAIYHGI EDSGPKRNIIVELQVCYGNNNRFPTESESRLVNQIIEEMIKVRVYVAWVPALEGIGGNQE IGPLVSQGFRQVLFLEKIEPAQEEHDKYHSNVKELVFKFGLPRIVARQIVDTCDKCHQKG EAIHGQVNSDLGTWQMDCTHLEGKIVIVAVHVASGFIEAEVIPQETGRQHYFLLKLAGRW PYLHIYTHSNGANFASQEVKMVTWWAGIEAHLWVPYNPQSQGVVEAMNHHLKNQIDRIRE QANSVETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQEIQFQQSKNSKFKNFRVYY REGRDQLWKGPGELLWKGEGAVILKVGTDIKVVPRRKAKIIKDYGGGKEVDSSSHMEDTG EAREVA >P12502|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate F236/smH4)|Swiss-Prot MGARNSVLSGKEADELEKVRLRPNGKKKYMLKHVVWAANELDRFGLAESLLDNKEGCQKI LSVLAPLVPTGSENLKSLYNTVCVIWCIHAEEKVKHTEEAKQIVQRHLVVETGTADRMPA TSRPTAPPSGRGGNYPVQQVGGNYVHLPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGEHQAAMQIIREIINEEAADWDLQHPQPGPLPAGQLREPRGSDIAGT TSTVDEQIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTNILDVKQGPKEPFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPGQ KARLMAEALKEALRPDQLPFAAVQQKGQRKTIKCWNCGKEGHSAKQCRAPRRQGCWKCGK TGHVMAKCPERQAGFFRAWPMGKEAPQFPHGPDASGADTNCSPRGSSCGSTEELHEDGQK AEGEQRETLQGGDRGFAAPQFSLWRRPVVTAYIEEQPVEVLLDTGADDSIVAGIELGPNY TPKIVGGIGGFINTKEYKDVKIKVLGKVIKGTIMTGDTPINIFGRNLLTAMGMSLNLPIA KVEPIKVTLKPGKEGPKLRQWPLSKEKIIALREICEKMEKDGQLEEAPPTNPYNTPTFAI KKKDKNKWRMLIDFRELNKVTQDFTEVQLGIPHPAGLAKRRRITVLDVGDAYFSIPLDEE FRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRNVLEPFRKANPDVTLIQY MDDILIASDRTDLEHDRVVLQLKELLNGIGFSTPEEKFQKDPPFQWMGYELWPTKWKLQK IELPQRETWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTLTEEVQWTEMAEAEY EENKIILSQEQEGCYYQEGKPIEATVIKSQDNQWSYKIHQEDKVLKVGKFAKVKNTHTNG VRLLAHVVQKIGKEALVIWGEVPKFHLPVEREIWEQWWTDYWQVTWIPDWDFVSTPPLVR LVFNLVKEPIQGAETFYVDGSCNRQSREGKAGYVTDRGRDKAKLLEQTTNQQAELEAFYL ALADSGPKANIIVDSQYVMGIIAGQPTESESRLVNQIIEEMIKKEAIYVAWVPAHKGIGG NQEVDHLVSQGIRQVLFLKKIEPAQEEHEKYHSNVKELVFKFGLPRLVAKQIVDTCDKCH QKGEAIHGQVNAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIPQETGRQTALFLLKL AGRWPITHLHTDNGANFTSQEVKMVAWWAGIEQTFGVPYNPQSQGVVEAMNHHLKTQIDR IREQANSIETIVLMAVHCMNFKRRGGIGDMTPAERLVNMITTEQEIQFQQSKNSKFKNFR VYYREGRDQLWKGPGELLWKGEGAVILKVGTEIKVVPRRKAKIIKDYGGGKELDSGSHLE DTGEAREVA >P19505|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate PBj14/BCL-3)|Swiss-Prot MGARNSVLSGKKADELEKIRLRPGGKKRYQLKHIVWAANELDRFGLAESLLENKEGCQKI LSVLAPLVPTGSENLKSLYNTVCVLWCIHAEEKVKHTEEAKQIVQRHLVVETGTADKMPA TSRPTAPPSGKGGNYPVQQIGGNYTHLPLSPRTLNAWVKLIEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGEHQAAMQIIREIINEEAADWDLQHPQPGPIPPGQLREPRGSDIAGT TSTVDEQIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTNILDVKQGPKEPFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGINPTLEEMLTACQGVGGPGQ KARLMAEALKDALTQGPLPFAAVQQKGQRKIIKCWNCGKEGHSARQCRAPRRQGCWKCGK AGHVMAKCPERQAGFFRAWPMGKEAPQFPHGPDASGADTNCSPRGSSCGSTEELHEDGQK AEGEQRETLQGGNGGFAAPQFSLWRRPIVTAYIEEQPVEVLLDTGADDSIVAGIELGPNY TPKIVGGIGGFINTKEYKDVKIKVLGKVIKGTIMTGDTPINIFGRNLLTAMGMSLNLPIA KVEPIKVTLKPGKDGPKLRQWPLSKEKIIALREICEKMEKDGQLEEAPPTNPYNTPTFAI KKKDKNKWRMLIDFRELNKVTQDFTEVQLGIPHPAGLAKRRRITVLDVGDAYFSIPLDEE FRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQHTMRNVLEPFRKANPDVTLIQY MDDILIASDRTDLEHDRVVLQLKELLNSIGFSTPEEKFQKDPPFQWMGYELWPTKWKLQK IELPQRETWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTLTEEVQWTEMAEAEY EENKIILSQEQEGCYYQEGKPLEATVIKSQDNQWSYKIHQEDKILKVGKFAKIKNTHTNG VRLLAHVVQKIGKEAIVIWGQVPRFHLPVEREIWEQWWTDYWQVTWIPEWDFVSTPPLVR LVFNLVKEPIQGAETFYVDGSCNRQSREGKAGYVTDRGRDKAKLLEQTTNQQAELEAFYL ALADSGPKANIIVDSQYVMGIVAGQPTESESRLVNQIIEEMIKKEAIYVAWVPAHKGIGG NQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNVKELVFKFGLPRLVAKQIVDTCDKCH QKGEAIHGQVNAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIPQETGRQTALFLLKL ASRWPITHLHTDNGANFTSQEVKMVAWWAGIEQTFGVPYNPQSQGVVEAMNHHLKTQIDR IREQANSIETIVLMAVHCMNFKRRGGIGDMTPAERLVNMITTEQEIQFQQSKNSKFKNFR VYYREGRDQLWKGPGELLWKGEGAVILKVGTEIKVVPRRKAKIIKDYGGGKELDSGSHLE DTGEAREVA >Q8AII1|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus (isolate TAN1)|Swiss-Prot MGARASVLRGDKLDTWESIRLKSRGRKKYLIKHLVWAGSELQRFAMNPGLMENVEGCWKI ILQLQPSVDIGSPEIISLFNTICVLYCVHAGERVQDTEEAVKIVKMKLTVQKNNSTATSS GQRQNAGEKEETVPPSGNTGNTGRATETPSGSRLYPVITDAQGVARHQPISPRTLNAWVR VIEEKGFNPEVIPMFSALSEGATPYDLNSMLNAVGEHQAAMQMLKEVINEEAAEWDRAHP AHAGPQQAGMLREPTGADIAGTTSTLQEQVLWMTTPQAQGGVPVGDIYKRWIILGLNKLV RMYSPVSILDIKQGPKEPFRDYVDRFYKTIRAEQASQPVKTWMTETLLVQNANPDCKHIL KALGQGATLEEMLTACQGVGGPSHKAKILAEAMASATAGGVNMLQGGKRPPLKKGQLQCF NCGKVGHTARNCRAPRKKGCWRCGQEGHQMKDCTTRNNSTGVNFFRETHPLVGVQTRELC AEHPREREGSGAGDSTDTSGANCPTTGDDDERRVLPQVNLWQRPMMTVKVQGQVCQALLD TGADDSVFCNIKLKGQWTPKTIGGIGGFVPVSEYYNIPVQIGNKEVRATVLVGETPINII GRNILKQLGCTLNFPISPIEVVKVQLKEGMDGPKVKQWPLSKEKIEALTEICKTLEKEGK ISAVGPENPYNTPIFAIKKKDTSKWRKLVDFRELNKRTQDFWELQLGIPHPAGLRKRNMV TVLDVGDAYFSIPLDPDFRKYTAFTIPSLNNNTPGKRFQYNVLPQGWKGSPAIFQSSMTK ILDPFRKEHPDVDIYQYMDDLYIGSDLNEEEHRKLIKKLRQHLLTWGLETPDKKYQEKPP FMWMGYELHPNKWTVQNITLPEPEQWTVNHIQKLVGKLNWASQIYHGIKTKELCKLIRGV KGLTEPVEMTREAELELEENKQILKEKVQGAYYDPKLPLQAAIQKQGQGQWTYQIYQEEG KNLKTGKYAKSPGTHTNEIRQLAGLIQKIGNESIIIWGIVPKFLLPVSKETWSQWWTDYW QVTWVPEWEFINTPPLIRLWYNLLSDPIPEAETFYVDGAANRDSKKGRAGYVTNRGRYRS KDLENTTNQQAELWAVDLALKDSGAQVNIVTDSQYVMGVLQGLPDQSDSPIVEQIIQKLT QKTAIYLAWVPAHKGIGGNEEVDKLVSKNIRKILFLDGINEAQEDHDKYHSNWKALADEY NLPPVVAKEIIAQCPKCHIKGEAIHGQVDYSPEIWQIDCTHLEGKVIIVAVHVASGFIEA EVIPEETGRETAYFILKLAGRWPVKKIHTDNGPNFTSTAVKAACWWAQIQHEFGIPYNPQ SQGVVESMNKQLKQIIEQVRDQAEQLRTAVIMAVYIHNFKRKGGIGEYTAGERLLDILTT NIQTKQLQKQILKVQNFRVYYRDARDPIWKGPARLLWKGEGAVVIKEGEDIKVVPRRKAK IIKEYGKQMAGAGGMDDRQNET >P27973|retroviral ribonuclease H|EC 3.1.26.13|Simian immunodeficiency virus agm.vervet (isolate AGM155)|Swiss-Prot MGAATSALNRRQLDEFEHIRLRPNGKKKYQIKHLIWAGKKMDRFGLHEKLLETEEGCKKI IEVLSPLEPTGSEGMKSLYNLVCVLLCVHQEKKVKDTEEALAIVRQCCHLVDKEKTAVTP PGGQQKNNTGGTATPGGSQNFPAQQQGNAWVHVPLSPRTLNAWVKAVEEKKFGAEIVPMF QALSEGCTPYDINQMLNVLGDHQGALQIVKEIINEEAAQWDVTHPPPAGPLPAGQLRDPG GSDIAGTTSTVQEQLEWIYTANPRVDVGAIYRRWIILGLQKCVKMYNPVSVLDIRQGPKE PFKDYVDRFYKAIRAEQASGEVKQWMTESLLIQNANPDCKVILKGLGMHPTLEEMLTACQ GVGGPSYKAKVMAEMMQNLQSQNMVQQGGGRGRPRPPPKCYNCGKFGHMQRQCPEPRKIK CLKCGKPGHLAKDCRGQVNFFRVWPVDGDKTKKFSRSHSWGGTKCAPSTEQLYTLRPSKE APAAVCRERETNEKSEQKPPSEQSRLERGIFFELPLWRRPIRTCIIGGTAVKALLDTGAD DTIIKDTDLQLRGSWRPKIVGGIGGGLNVKEYDNVEVQLEDKILRGTVLIGATPINIIGR NFLAQAGAKLVMGQLSQTIPITPVRLKEGARGPRLKQWPLSKEKIIALQEICKTLEEEGK LSRVGGDNAYNTPVFCIRKKDKSQWRMLVDFRELNKATQDFFEVQLGIPHPAGLKKMKQI TIIDVGDAYYSIPLDPEFRKYTAFTIPTVNNEGPGIRYQFNCLPQGWKGSPTIFQNTASK ILEEIKKELKQLTIVQYMDDLWVGSQEEGPKHDQLVQTLRNRLQEWGLETPEKKVQREPP FEWMGYKLWPHKWKLQSIELEKKEQWTVNDLQKLVGKLNWAAQLYPGLRTKNICKLLRGK KNLLDVVEWTPEAEAEYEENKEILKTEQEGTYYAPEKPLRAAVQKLGDGQWSYQFKQEGK ILKVGKFAKQKATHTNELRVLAGVVQKIGKEALVIWGQLPTFELPVERDTWEQWWADYWQ VSWIPEWDFVSVPPLVTLWYTLTKEPIPGEDVYYVDGACNRQSKEGKAGYITQQGKQRVQ QLENTTNQQAELTAIKMALEDSGPKVNIVTDSQYAMGILTAQPTQSDSPLVEQIIAQMVQ KEAIYLQWVPAHKGIGGNEEIDKLVSKGVRRILFIGRIEEAQEEHDRYHSNWRNLADTFG LPQIVAKEIVAMCPKCQVKGEPIHGQVDASPGVWQMDCTHIEGKIVIVAVHVASGFIEAE VIPRETGKETAKFLLKIIGRWPITHLHTDNGPNFTSQEVAAMCWWGKVEHTTGVPYNPQS QGSIESMNKQLKEIIGKIRDDCQYTETAVLMACHIHNFKRKGGIGGLTAAERLINMITTQ LEINTLQTKIQKILNFRVYYREGRDPVWKGPARLIWKGEGAVVLKEGEELKVVPRRKAKI IKDYEPRKTLGDETHLEGAGGSDHQMAGDS >O93215|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype H (isolate 90CF056)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGKKKYRLKHLVWASRELERFALNPGLLETPEGCLQI IEQIQPAIKTGTEELKSLFNLVAVLYCVHRKIDVKDTKEALDKIEEIQNKSQQKTQQAAA DKEKDNKVSQNYPIVQNAQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNAMLNTVGGHQAAMQMLKDTINEEAAEWDRVHPVHAGPIPPGQMREPRGSDIAGTT STLQEQIAWMTGNPAIPVGDIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVDRF FKTLRAEQATQDVKNWMTETLLVQNANPDCKTILRALGQGASIEEMMTACQGVGGPSHKA RVLAEAMSQVTNTNTAIMMQKGNFKGQRKFVKCFNCGKEGHIARNCRAPRKKGCWKCGRE GHQMKDCTERQAKFFRENLAFQQREARKFSPEQARTNSPTSRELRVRRGDDPLSEAGAAE GQGTSLSFPQITLWQRPLVTVKIEGQLREALLDTGADDTVLEEINLPGKWKPKMIGGIGG FIKVRQYEQVAIEICGKKAIGTVLVGPTPVNIIGRNILTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALTEICTEMEKEGKISRIGPENPYSTPIFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVSVLDVGDAYFSVPLDKEFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILAPFREQNPEMVIYQYMDDLYVGSDL EIGQHRAKIEELRAHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQTVKLPEKDSWT VNDIQKLVGKLNWASQIYPNIKVKQLCKLLRGAKALTDIIPLTKEAELELAENREILREP IHGVYYDPSKDLIAEIRKQGQGQWTYQIYQEPFKNLKTGKYAKMRTAHTNDIKQLTEAVQ KISTESIVIWGKIPKFRLPIQKETWETWWTEYWQATWIPEWEFVNTPHLVKLWYQLETEP IAGAETYYIDGAANRETKLGKAGYVTDRGKQKVVSLTETTNQKTELQAIYLALQDSGLEV NIVTDSQYALGIIQAQPDKSESELVNQIIEELIKKEKVYLSWVPAHKGIGGNEQVDKLVS SGVRKVLFLDGIDKAQEEHERYHNNWRAVASDFNLPPIVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGQVILVAVHVASGYIEAEVIPAETGKETAYFLLKLASRWPVKVI HTDNGSNFTSAAVKAACWWADIQQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQISNIQKFRVYYRDSRDP IWKGPAKLLWKGEGAVVIQDNSEIKVVPRREAKIIRDYGKQMAGDDCVASRQDED >O12158|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype C (isolate 92BR025)|Swiss-Prot MGARASILRGGKLDAWERIKLKPGGKKHYMMKHLVWASRELERFALDPGLLETSEGCKQI MKQLQPALQTGTKELISLHNTVATLYCVHEKIDVRDTKEALDKIKEEQNKSQQKTQQAEA ADKGKVSQNYPIVQNLQGQMVHQPISARTLNAWVKVVEEKAFSPEVIPMFTALSEGATPQ DLNTMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPVAPGQMREPRGSDIAGTTST LQEQITWMTNNPPVPVGDIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVDRFFK TLRAEQATQDVKNWMTDTLLVQNANPDCKTILRALGPGASLEEMMTACQGVGGPGHKARV LAEAMSKVNNTNIMMQRSNCKGPKRTIKCFNCGKEGHLARNCRAPRKKGCWKCGKEGHQV KDCTERQANFFRENLAFPQGEARKSSSEQNRANSPTRRELQVWGRDNNSLSEAGDDRQGT ALNFPQITLWQRPLVNIKVGGQLKEALLDTGADDTVLEEIKLPGNWKPKMIGGIGGFIKV RQYDQILIEICGKKAIGTVLVGPTPVNIIGRNMLTQLGCTLNFPISPIETVPVKLKPGMD GPKVKQWLLTEEKIKALTAICDEMEREGKITKIGPENPYNTPVFAIKKKDSTKWRKLVDF RELNKRTWDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEGFRKYTAFTIPSINN ETPGIRYQYNVLPQGWKGSPSIFQSSTTKILEPFRAQNPEIIIYQYMDDLYVGSDLEIGQ HRAKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKDSWTVNDI QKLVGKLNWASQIYPGIKVRQLCKLLRGAKALTDIVPLTEEAELELAENREILKEPVHGV YYDPSKDLIAEIQKQGQNQWTYQIYQEPFKNLKTGKYAKMRTAHTNDVRQLTEAVQKIAL ESIIIWGKTPKFRLPIQKETWEAWWTDYWQATWIPEWEFVNTPPLVKLWYQLEKEPIAGA ETFYVDGAANREIKMGKAGYVTDRGRQKIVSITETTNQKTELQAIQLALQDSGSEVNIVT DSQYALGIIQAQPDKSESELVNQIIEQLIKKERVYLSWVPAHKGIGGNEQVDKLVSSGIR KVLFLDGINKAQEEHEKYHSNWRAMASEFNLPPIVAKEIVASCDKCQLKGEATHGQVDCS PGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKVIHTDN GSNFISNTVKAACWWAGIQQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQ MAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQIMKIQNFRVYYRDSRDPIWKG PAKLLWKGEGAVVLQDNSDIKVVPRRKVKIIKDYGKQMAGADCMASRQDED >O89290|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype F1 (isolate 93BR020)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGKKKYRLKHLVWASRELERFALDPGLLETSEGCRKI IGQLQPSLQTGSEELKSLYNTIAVLYYVHQKVEVKDTKEALEKLEEEQNKGRQKTQQATA EKGVSQNYPIVQNLQGQMVHQSLSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGATPQDL NTMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPTQAGPIPPGQIREPRGSDIAGTTSTLQ EQIQWMTGNPPVPVGEMYKRWIILGLNKIVRMYSPVGILDIRQGPKEPFRDYVDRFFKTL RAEQATQEVKGWMTDTLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPSHKARVLA EAMSQATNTAIMMQKSNFKGQRRIVKCFNCGKEGHIAKNCRAPRKKGCWKCGREGHQMKD CTERQAKFFRENLAFQQGEARKLHPEQARAVSPASRELQVRGGDNPISEAGAERRGTVPS LSFPQITLWQRPLVTIRVGGQLKEALLDTGADDTVLEDVNLPGKWKPKMIGGIGGFIKVK QYDSILIEICGHRAIGTVLVGPTPVNIIGRNMLTQIGCTLHFPISPIETVPVKLKPGMDG PKVKQWPLTEEKIKALTEICMEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFR ELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTASTIPSTNNE TPGVRYQYNVLPQGWKGSPAIFQYSMTKILDPFRAKNPDIVIYQYMDDLYVGSDLEIGQH RTKIEELREHLLKWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPDKDSWTVNDIQ KLVGKLNWASQIYPGIKVKQLCKLLRGAKALTDIVPLTTEAELELAENREILKEPVHGAY YDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYAKMRSAHTNDVKQLTEAVQKISLE SIVIWGKTPKFRLPILKETWDTWWTEYWQATWIPEWEFVNTPPLVKLWYQLETEPIVGAE TFYVDGASNRETKKGKAGYVTDRGRQKAVSLTETTNQKAELQAIQLALQDSGSEVNIVTD SQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLSWVPAHKGIGGNEQVDKLVSAGIRK VLFLDGIDKAQEEHEKYHNNWRAMASDFNIPAVVAKEIVASCDKCQLKGEAMHGQVDCSP GIWQLDCTHLEGKIILVAVHVASGYLEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNG TNFTSATVKAACWWAGIQQEFGIPYNPQSQGVVESMNKELKKIIGQIRDQAEHLKTAVQM AVFIHNFKRKGGIGGYSAGERTIDIIATDIQTRELQKQIIKIQNFRVYYRDSRDPVWKGP AKLLWKGEGAVVIQDNSEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >Q9QBY3|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype K (isolate 96CM-MP535)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGKKKYKLKHLVWASRELERFALNPGLLETTEGCRQI ITQIQPSIQTGSEEIKSLYNTIAVLYFVHQKIEVKDTKEALDKLEEEQNKSQRKTQQEAA DKGVSQNYPIVQNLQGQMVHQALSPRTLNAWVKVIEEKAFSPEVIPMFTALSEGATPQDL NTMLNTVGGHQAAMQMLKDTINDEAAEWDRLHPVHAGPIPPGQMREPRGSDIAGTTSTLQ EQIAWMTSNPPVPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRFFKTL RAEQATQEVKNWMTDTLLVQNANPDCKTILKALGPGASLEEMMTACQGVGGPSHKARILA EAMSQVTNPVVMMQKGNFKGHRKIVKCFNCGKEGHIARNCRAPRKKGCWKCGKEGHQMKD CTERQANFFRENLAFPQGEAREFSSEQTRANSPTSRELRVRGGDNPLSEAGDQRQGTEPS FNFPQITLWQRPIVTIKVGGQLREALLDTGADDTVLEEINLPGKWKPKMIGGIGGFIKVR QYDQVLIEICGQKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLKPGMDG PKVKQWPLTEEKIKALTEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFR ELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNE TPGVRYQYNVLPQGWKGSPAIFQHSMTKILEPFRIKNPEMVIYQYMDDLYVGSDLEIGQP RTKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPDKDSWTVNDIQ KLVGKLNWASQIYPGIKVKQLCKLLRGVKALTDIVPLTAEAELELAENREILKEPVHGVY YDPSKDLIAEIQKQGNDQWTYQIYQEPHKNLKTGKYARMRSAHTNDVKQLTEAVQKIATE GIVIWGKTPKFRLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLETEPIVGAE TFYVDGAAHRETKKGRAGYVTDRGRQKVVSITETTNQKAELQAICLALQDSGSEVNIVTD SQYALGIIQAQPDKSESDLVNQIIEQLIKKERIYLSWVPAHKGIGGNEQVDKLVSAGIRK VLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPIVAKEIVASCDKCQLKGEAIHGQVDCSP GIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKVIHTDNG TNFTSTVVKAACWWAGVKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQM AVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQILNIQKFRVYYRDSREPIWKGP AKLLWKGEGAVVIQDNSEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >Q9QBZ9|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype K (isolate 97ZR-EQTB11)|Swiss-Prot MGARASVLSGGKLDKWEKIQLRPGGKKKYRLKHLVWASRELERFALNPNLLETVEGCRQI IRQLQPSLQTGSEELRSLFNTVATLYWVHQSIQVRDTKEALDKLEEEQNRTQQKTQQGKA DKGVSQNYPIVQNLQGQMVHQALSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGATPQDL NTMLNTVGGHQAAMQMLKDTINEEAAEWDRMHPVQAGPIPPGQIREPRGSDIAGTTSTLQ EQITWMTSNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRFFRVL RAEQATQEVKNWMTETLLVQNANPDCRTILKALGSGATLEEMMTACQGVGGPGHKARVLA EAMSQVTNSAVMMQRGNFKGQRRIIKCFNCGKEGHLARNCRAPRKKGCWKCGKEGHQMKD CSERQANFFREVLASQQREARKFSSEQTRANSPTSRELWVRGEDNPLSETGNERSGTGSS FNFPQITLWQRPVVTVKVGGQLREALLDTGADDTVLEEINLPGKWKPKMIGGIGGFIKVR QYDQVCMEICGQKAIGTVLVGPTPVNIIGRNMLTQIGCTLNFPISPIETVPVKLKPGMDG PKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWIKLVDFR ELNKRTPDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNE TPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRRKNPDMVLYQYMDDLYVGSDLEIGQH RAKIEELREHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPDKDSWTVNDIQ KLVGKLNWASQIFPGIKVKQLCKLLRGVKALTDIVPLTAEAELELAENREILKEPVHGVY YDPSKDLIAEIQKQGHGQWTYQIYQEPYKNLKTGKYARIRSAHTNDVKQLTEVVQKVAME SIVIWGKTPKFRLPIQKETWGTWWTEYWQATWIPEWEFVNTPPLVKLWYQLETEPIVGAE TFYVDGAANRETKQGKAGYVTDKGRQKVISITETTNQKTELQAIHLALQDSGSEVNIVTD SQYALGIIQAQPDKSESELVNQIIEQLIKKDRVYLSWVPAHKGIGGNEQVDKLVSSGIRK VLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAIHGQVDCSP GIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVRVIHTDNG SNFTSAVVKAACWWADIKQEFGIPYNPQSQGVVESMNKELKKIIGQVREQAEHLKTAVQM AVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQITKIQNFRVYYRDSREPIWKGP AKLLWKGEGAVVIQNSEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >O41798|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype G (isolate 92NG083)|Swiss-Prot MGARASVLSGGKLDSWEKIRLRPGGRKKYKLKHIVWASRELGRFALNRDLLETAEGCVQI MKQLQPALTGTEELRSLFNTVATLYCVHQKIEVKDTKEAPEEVEKIQKNSQQEIQQAAKN EGNSNPVSQNYPIVQNAQGQMIHQAISPWTLNAWVKVVEEKAFSPEVIPMFSALSEGATP QDLNTMLNTVGGHQAAMQMLKDTINDEAAEWDRIHPQQAGPIPPGQIREPSGSDIAGTTS TLQEQIRWMTSNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRFF KTLRAEQATQEVKGWMTDTLLVQNANPDCKTILRALGPGATLEEMMTACQGVGGPSHKAR VLAEAMSQASGAAAAAIMMQKSNFKGPRRIIKCFNCGKEGHLARNCRAPRKKGCWKCGKE GHQMKECTERQANFLRENLAFQQGEARKLSPEQDRANSPTSRELRIRRGDSPLPEAGAKG EGAISLNFPQITLWQRPLVTVKIGGQLIEALLDTGADDTVLEGINLPGKWKPKMIGGIGG FIKVRQYDQILIEIGGKKAIGTVLVGPTPINIIGRNMLTQIGCTLNFPISPIETVPVKLK PGMDGPRVKQWPLTEEKIKALTEICKDMEKEGKISKIGPENPYNTPIFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKRSVTVLDVGDAYFSVPLDKDFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPSRTKNPEMVIYQYMDDLYVGSDL EIGQHRAKIEELREHLLKWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKEDWT VNDIQKLVGKLNWASQIYPGIKVKHLCRLLRGAKALTDIVPLTAEAEMELAENREILKEP VHGVYHDPSKELIAEVQKQGPDQWTYQIYQEPYKNLKTGKYAKRGSAHTNDVKQLTEVVQ KIATEGIVIWGKIPKFKLPIRKETWEVWWTEYWQAAWIPEWEFVNTPPLVKLWYQLETEP IPGAETYYVDGAANRETKLGKAGHVTDKGKQKIITLTETTNQKAELHAIQLALQDSRPEV NIVTDSQYALGIIQAQPDRSGSELVNQIIEQLIKKEKVYLSWVPAHKGIGGNEQVDKLVS SGIRKVLFLDGIDKAQEEHERYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKIIIVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKVI HTDNGPNFISAAVKAACWWANITQEFGIPYNPQSQGVVESMNKELKKIIGQVGDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIIDIIASDIQTKELQKQIIKIQNFRVYYRDSRDP IWKGPAKLLWKGEGAVVIQDNNEIKVVPRRKAKILKDYGKQMAGGDCVAGRQDED >P03369|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)|Swiss-Prot MGARASVLSGGELDKWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQRIDVKDTKEALEKIEEEQNKSKKKAQQAAA AAGTGNSSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEG ATPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAG TTSTLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVD RFYKTLRAEQASQDVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGH KARVLAEAMSQVTNPANIMMQRGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWRCGR EGHQMKDCTERQANFLREDLAFLQGKAREFSSEQTRANSPTRRELQVWGGENNSLSEAGA DRQGTVSFNFPQITLWQRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGI GGFIKVRQYDQIPVEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVK LKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKW RKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFT IPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGS DLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIMLPEKDS WTVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGTKALTEVIPLTEEAELELAENREILK EPVHEVYYDPSKDLVAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEA VQKVSTESIVIWGKIPKFKLPIQKETWEAWWMEYWQATWIPEWEFVNTPPLVKLWYQLEK EPIVGAETFYVDGAANRETKLGKAGYVTDRGRQKVVSIADTTNQKTELQAIHLALQDSGL EVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKL VSAGIRKVLFLNGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMH GQVDCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVK TIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNNELKKIIGQVRDQAEH LKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDNK DPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >Q77373|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group O (isolate ANT70)|Swiss-Prot MGASASVLTGSKLDAWEQIRLKPGSKKKYRLKHLVWASRELERFACNPELLETAEGNEKL LQQLEPALKTGSDSLQSLWNAIVVLWCVHNRYKIGDTQQAIQKLKEVMGSRKSADAAKED TSARQAGQNYPIVSNAQGQMVHQAISPRTLNAWVKAVEEKAFNPEIIPMFMALSEGAISY DINTMLNAIGGHQGALQVLKEVINEEAVEWDRTHPPPVGPLPPGQIREPTGSDIAGTTST QQEQIHWTTRPNQPIPVGDIYRKWIVLGLNKMVKMYSPVSILDIKQGPKEPFRDYVDRFY KTLRAEQATQEVKNWMTETLLVQNANPDCKQILKSLGPGATLEEMMVACQGVGGPTHKAR VLAEAMATAQQDLKGGYTAVFMQRGQNPIRKGTIKCFNCGKEGHIARNCRAPRKKGCWKC GQEGHQMKDCRNGKQFFRQILASGGHEARQLCAETSTPISPTDGGGSEGTGESGTERGPE RALSVCLPQIPLWDRPIVTARVGGHLCEVLLDTGADDTVLNNIQLEGKWKPKMIGGIGGF IKVKEYDNVTVEIEGREVQGTVLVGPTPVNIIGRNILTGLGCTLNFPISPIAPVPVKLKP GMDGPKVKQWPLSKEKIEALTAICQEMEQEGKISRIGPENPYNTPIFAIKKKDGTKWRKL VDFRELNKRTQEFWEVQLGIPHPGGLKQKQSVTVLDVGDAYFSCPLDPDFRKYTAFTIPS VNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILDPFRRDNPELEICQYMDDLYVGSDLP LTEHRKRIELLREHLYQWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQSIQLPNKDVWTV NDIQKLIGKLNWASQIYQGIRVRELCKLIRGTKSLTEVVPLSREAELELEENRERLKQPV HGVYYQPDKDLWVNIQKQGGEQWTYQIYQEEHKNLKTGKYTRQKASHTNDIRQLAEVIQK VSQESIIIWGKLPKFKLPVTRETWETWWADYWQATWIPEWEFVSTPPLIKLWYRLESEPI MGAETYYVDGAANRETKLGKAGYVTEQGKQKIIKLDETTNQKAELMAILLALQDSKETVN IVTDSQYALGVISSQPTQSESPIVQQIIEELTKKEQVYLTWVPAHKGIGGNEKIDKLVSK DIRRVLFLEGIDQAQEDHEKYHSNWKALASEFGLPPVVAKEIIASCPKCHIKGEAIHGQV DCSPEVWQIDCTHMEGKIIIVAVHVASGFIEAEVIPAETGQETAYFLLKLAARWPVKVIH TDNGPNFTSTTMKAACWWANIQHEFGIPYNPQSQGVVEAMNKELKSIIQQVRDQAEHLRT AVQMAVFVHNFKRKGGIGGYTAGERIIDILASQIQTTELQKQILKXHKFRVYYRDSRDPI WKGPAQLLWKGEGAVVIQDKGDIKVVPRRKAKIIREYGKQMAGTDSMASGQTESE >P03366|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate BH10)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQRIEIKDTKEALDKIEEEQNKSKKKAQQAAA DTGHSSQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNTATIMMQRGNFRNQRKMVKCFNCGKEGHTARNCRAPRKKGCWKCGKEG HQMKDCTERQANFLREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGR DNNSPSEAGADRQGTVSFNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPG RWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFP ISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVF AIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLD EDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVIY QYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTV QPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAEL ELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAH TNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPP LVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTTNQKTELQA IYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKG IGGNEQVDKLVSAGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCD KCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFL LKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKI IGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQ NFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCV ASRQDED >P04587|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate BH5)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQRIEIKDTKEALDKIEEEQNKSKKKAQQAAA DTGHSSQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSTTIMMQRGNFRNQRKIVKCFNCGKEGHIARNCKAPRKKGCWKCGKEG HQMKDCTERQANFLREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGR DNNSPSEAGADRQGTVSFNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPG RWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFP ISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVF AIKKKDSTKWRKLVDFRELNRRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLD EDFRKYTAFTIPSINNETPGSGYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIY QYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTI QPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAEL ELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAH TNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPP LVKLWYQLEKEPIVGAETFYVDGAASRETKLGKAGYVTNRGRQKVVTLTHTTNQKTELQA IHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKG IGGNEQVDKLVSAGIRKILFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCD KCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFL LKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKI IGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQ NFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCV ASRQDED >Q73368|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (strain 89.6)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPSLLETSEGCRQI LGQLQSSLQTGSEELKSLYNTVATLYCVHQRIEVKDTKEALDKIEEEQNKSKKKAQQAAA DTGNSSQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVQAGPVAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPSSILDIKQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSATIMMQRGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGKEG HQMKDCTERQANFFRENLAFPQGKAREFSSEQTRANSPTRRELQVWGGDNNSLSEAGADR QGTVSLSFPQITLWQRPLVTIKVGGQLKEALLDTGADDTVLEDMSLPGRWKPKMIGGIGG FIKVRQYEQIDIEICGHKAKGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDL EIGQHRAKIEDLRQHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT VNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGTKALTEVVPLTEEAELELAENREILKEP VHGVYYDPTKDLIAELQKQGQGQWTYQIYQEPYKNLKTGKYARMRGAHTNDVKQLTEAVQ KIATESIVIWGKTPKFKLPIQKETWEAWWTDYWQATWIPEWEFVNTPPLVKLWYQLEKEP IVGAETFYVDGAANRDTKSGKAGYVTDRGRQKVVSLADTTNQKTELQAIHLALQDSGLEV NIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS AGIRKVLFLDGIDKAQEEHEKYHTNWRAMASDFNLPPVVAKEIVASCNKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTI HTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIASDIQTKELQKQITKIQNFRVYYRDSRDP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >P03367|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQRIEIKDTKEALDKIEEEQNKSKKKAQQAAA DTGHSSQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSATIMMQRGNFRNQRKIVKCFNCGKEGHIARNCRAPRKKGCWKCGKEG HQMKDCTERQANFLREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGR DNNSLSEAGADRQGTVSFNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPG RWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFP ISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVF AIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLD EDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIY QYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTV QPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAEL ELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARTRGAH TNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPP LVKLWYQLEKEPIVGAETFYVDGAASRETKLGKAGYVTNRGRQKVVTLTDTTNQKTELQA IHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKG IGGNEQVDKLVSAGIRKVLFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCD KCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFL LKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKI IGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQ NFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCV ASRQDED >P04589|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype D (isolate ELI)|Swiss-Prot MGARASVLSGGKLDKWEKIRLRPGGKKKYRLKHIVWASRELERYALNPGLLETSEGCKQI IGQLQPAIQTGTEELRSLYNTVATLYCVHKGIDVKDTKEALEKMEEEQNKSKKKAQQAAA DTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVIEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIAWMTSNPPIPVGEIYKRWIIVGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRF YKTLRAEQASQDVKNWMTETLLVQNANPDCKTILKALGPQATLEEMMTACQGVGGPSHKA RVLAEAMSQATNSVTTAMMQRGNFKGPRKIIKCFNCGKEGHIAKNCRAPRKKGCWRCGKE GHQLKDCTERQANFLRENLAFPQGKAGELSPKQTRANSPTSRELRVWGRDNPLSKTGAER QGTVSFNFPQITLWQRPLVAIKIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGG FIKVRQYDQIPIEICGQKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALTEICTDMEKEGKISRIGPENPYNTPIFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIS SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEMVIYQYMDDLYVGSDL EIGQHRTKIEKLREHLLRWGFTRPDKKHQKEPPFLWMGYELHPDKWTVQSIKLPEKESWT VNDIQNLVERLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGHGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLAEAVQ RISTESIVIWGRTPKFRLPIQKETWETWWAEYWQATWIPEWEFVNTPPLVKLWYQLEKEP IIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAINLALQDSGLEV NIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS QGIRKVLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKVV HTDNGSNFTSAAVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRRRGIGGYSAGERIIDIIATDIQTKELQKQIIKIQNFRVYYRDSRDP IWKGPAKLLWKGEGAVVIQDKSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED >Q75002|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype C (isolate ETH2220)|Swiss-Prot MGARASILRGEKLDAWEKIKLRPGGKKHYMLKHLVWANRELEKFALNPDLLDTSAGCKQI IKQLQPALQTGTEELKSLFNTVATLYCVHQKIEIKDTKEALDKIEEEQNESQQKTQQAGA ADRGKDSQNYPIVQNMQGQMVHQPISARTLNAWVKVVEEKAFSPEVIPMFTALSEGATPQ DLNTMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPVAPGQMRDPRGSDIAGTTST LQEQIAWMTGNPPVPVGDIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVDRFFK TLRAEQATQDVKNWMTDTLLVQNANPDCKTILRALGPGASLEEMMTACQGVGGPAHKARV LAEAMSQVNNTTIMMQKSNFKGPKRAIKCFNCGKEGHLARNCRAPRKKGCWKCGKEGHQM KDCTERQANFFRETLAFQQGKAREFPSEQTRANSPTRESQTRANSPTTRELQVRGSNTFS EAGAERQGSLNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEINLPGKWKPKMIG GIGGFIKVRQYDQIIIEICGKKAIGTVLVGPTPVNIIGRNMLTQLGRTLNFPISPIETVP VKLKPGMDGPKVKQWPLTEEKIKALTAICEEMEQEGKISRIGPENPYNTPVFAIKKKDST KWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEGFRKYTA FTIPSTNNETPGIRYQYNVLPQGWKGSPPIFQSSMPQILEPFRAPNPEIVIYQYMDDLYV GSDLEIGQHRAPIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEK DSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGAKALTDIVTLTEEAELELAENREI LKEPVHGVFYDPSKDLIAEIQKQGNDQWTFQFYQEPFKNLKTGKFAKRGTAHTNDVKQLT AVVQKIALESIVIWGKTPKFRLPIQKETWEAWWTDYWQATWIPEWEFVNTPPLVKLWYQL EKEPIAGVETFYVDGAANRETKIGKAGYVTDRGRQKIVSLTETTNQKTELQAIQLALQDS GSEVNIVTDSQYALGIILAQPDKSESEIVNQIIEQLISKERVYLSWVPAHKGIGGNEQVD KLVSSGIRKVLFLDGIDKAQEEHEKYHSNWRAMANEFNIPPVVPKEIVACCDKCQLKGEA IHGQVNCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWP VRVIHTDNGSNFTSNAVKAACWWAGIQQEFGIPYNPQSQGVVESMNKELKKIIGQVREQA EHLKTAVQMAVFIHNFKRRGGIGGYSAGERIIDIIASDIQTKELQNQILKIQNFRVYYRD SRDPIWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGADCVAGRQDED >P04585|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQRIEIKDTKEALDKIEEEQNKSKKKAQQAAA DTGHSNQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSATIMMQRGNFRNQRKIVKCFNCGKEGHTARNCRAPRKKGCWKCGKEG HQMKDCTERQANFLREDLAFLQGKAREFSSEQTRANSPTRRELQVWGRDNNSPSEAGADR QGTVSFNFPQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGG FIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDL EIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT VNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQ KITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEP IVGAETFYVDGAANRETKLGKAGYVTNRGRQKVVTLTDTTNQKTELQAIYLALQDSGLEV NIVTDSQYALGIIQAQPDQSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS AGIRKVLFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTI HTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >P20875|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate JRCSF)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYRLKHIVWASRELERFAVNPGLLESSEGCRQI LGQLQPSLKTGSEELTSLYNTVATLYCVHQRIEIKDTKEALEKIEEEQTKSMKKAQQAAA DTGNSSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVIEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRF YKTLRAEQATQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNPATIMMQRGNFRNQRKNVKCFNCGKEGHIARNCRAPRKKGCWKCGKEG HQMKECTERQANFLREDLAFLQGKAREFPSEQTRANSPTRRELQVWGRDSNSLSEAGAEA GADRQGIVSFNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEDMDLPGRWKPKMIG GIGGFIKVRQYDQIPIDICGHKAVGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVP VKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDST KWRKLVDFRELNRRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTA FTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIIIYQYMDDLYV GSDLEIGQHRTKIEELRQHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEK DSWTVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGTKALTEVIPLTKEAELELAENREI LKEPVHGVYYDPSKDLIVEIQKQGQGQWTYQIFQEPFKNLKTGKYARTRGAHTNDVKQLT EAVQKIANESIVIWGKIPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQL EKEPIVGAETFYVDGAANRETKLGKAGYVTSRGRQKVVSLTDTTNQKTELQAIHLALQDS GLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVD KLVSAGIRKVLFLDGIDKAQEDHEKYHSNWRAMASDFNLPPIVAKEIVASCDKCQLKGEA MHGQVDCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWP VTTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQA EHLKTAVQMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQITKIQNFRVYYRD NRDPIWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED >P0C6F2|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate LW123)|Swiss-Prot MGARASVLSGGKLDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEECRSLYNTVATLYCVHQRIEIKDTKEALDKIKEEQNKSKKKAQQAAA DTGHSSQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSATIMMQRGNFRNQRKIVKCFNCGKEGHIARNCRAPRKKGCWKCGKEG HQMKDCTERQANFFREDLAFLQGKAREFSSEQTRANSPTRRELQVWGRDNNSPSEAGADR QGTVSFNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGG FIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDL EIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT VNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGTHTNDVKQLTEAVQ KITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEP IVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTTNQKTELQAIYLALQDSGLEV NIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS AGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTI HTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >Q9QBZ1|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype F2 (isolate MP257)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGKKKYRLKHIVWASRELKRFALNPGLLETTEGCKKI IGQLQPSLQTGSEELKSLFNTIVVLYYVHQKIEVRDTKEALDKLQEEQDKHQQKTQQATA DKGVSKGVSQNYPILQNLQGQMVHQSLSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPIPPGQMREPRGSDIAGTT STLQEQIAWMTSNPPVPVGEIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVDRF FKTLRAEQATQEVKGWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPSHKA RILAEAMSKATGAAIMMQKSNFKGQRRIVKCFNCGKEGHIARNCRAPRKRGCWKCGQEGH QMKDCTERQANFFRENVAFQQGEARKFSSEQTRANSPASRELRVRGGDSSLPEAGAERQG TGSSLDFPQITLWQRPVVTIKVGGQLREALLDTGADDTVLEDINLPGKWKPKMIGGIGGF IKVRQYDQVSIEICGQKAIGTVLVGPTPVNIIGRNMLTQIGCTLNFPISPIETVPVKLKP GMDGPKVKQWPLTEEKIKALTEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKL VDFRELNKRTQDFWEVQLGIPHPAGLKKKRSVTVLDVGDAYFSVPLDKEFRKYTAFTIPS INNETPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKENPEIVIYQYMDDLYVGSDLE IGQHRAKIEELREHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQAIQLPDKSSWTV NDIQKLVGKLNWASQIYPGIRVKHLCKLLRGTKALTDVVPLTAEAELELAENREILKEPV HGVYYDPSKDLIAEIQKQGHDQWTYQIYQEPHKNLKTGKYARRKSAHTNDVKQLTEVVQK VATEGIVIWGKVPKFRLPIQKETWEIWWTEYWQATWIPEWEFVNTPPLVKLWYQLETEPI IGAETFYVDGAANRETKLGKAGYITDRGRQKVVSLTETTNQKTELQAIQLALQDSGSEVN IVTDSQYALGIIQAHPDKSESEIVNQIIEQLIQKERVYLSWVPAHKGIGGNEQVDKLVST GIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQV DCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQEAAYFILKLAGRWPVKIIH TDNGSNFTSAVVKAACWWAGIQQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKT AVQMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQISKIQNFRVYFRDSRDPV WKGPAKLLWKGEGAVVIQDNNEIKVIPRRKAKIIRDYGKQMAGDDCVAGRQDED >P04588|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype A (isolate MAL)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGKKKYRLKHLVWASRELERFALNPGLLETGEGCQQI MEQLQSTLKTGSEEIKSLYNTVATLYCVHQRIDVKDTKEALDKIEEIQNKSRQKTQQAAA AQQAAAATKNSSSVSQNYPIVQNAQGQMIHQAISPRTLNAWVKVIEEKAFSPEVIPMFSA LSEGATPQDLNMMLNIVGGHQAAMQMLKDTINEEAADWDRVHPVHAGPIPPGQMREPRGS DIAGTTSTLQEQIGWMTSNPPIPVGDIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFR DYVDRFFKTLRAEQATQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVG GPSHKARVLAEAMSQATNSTAAIMMQRGNFKGQKRIKCFNCGKEGHLARNCRAPRKKGCW KCGKEGHQMKDCTERQANFLRENLAFPQGKAREFPSEQTRANSPTSRELRVWGGDKTLSE TGAERQGIVSFSFPQITLWQRPVVTVRVGGQLKEALLDTGADDTVLEEINLPGKWKPKMI GGIGGFIKVRQYDQILIEICGKKAIGTILVGPTPVNIIGRNMLTQIGCTLNFPISPIETV PVKLKPGMDGPRVKQWPLTEEKIKALTEICKDMEKEGKILKIGPENPYNTPVFAIKKKDS TKWRKLVNFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYT AFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRTKNPEIVIYQYMDDLY VGSDLEIGQHRTKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPD KESWTVNDIQKLVGKLNWASQIYPGIKVKQLCKLLRGAKALTDIVPLTAEAELELAENRE ILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEQYKNLKTGKYARIKSAHTNDVKQL TEAVQKIAQESIVIWGKTPKFRLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQ LETEPIVGAETFYVDGAANRETKKGKAGYVTDRGRQKVVSLTETTNQKTELQAIHLALQD SGSEVNIVTDSQYALGIIQAQPDKSESEIVNQIIEQLIQKDKVYLSWVPAHKGIGGNEQV DKLVSSGIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPIVAKEIVASCDKCQLKGE AMHGQVDCSPGIWQLDCTHLEGKIIIVAVHVASGYIEAEVIPAETGQETAYFILKLAGRW PVKVVHTDNGSNFTSAAVKAACWWANIKQEFGIPYNPQSQGVVESMNKELKKIIGQVREQ AEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIIDMIATDIQTKELQKQITKIQNFRVYYR DNRDPIWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVAGGQDED >P05961|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate MN)|Swiss-Prot MGARASVLSGGELDRWENIRLRPGGKKKYKLKHVVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELKSLYNTVATLYCVHQKIEIKDTKEALEKIEEEQNKSKKKAQQAAA DTGNRGNSSQVSQNYPIVQNIEGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSE GATPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPITPGQMREPRGSDIA GTTSTLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPSSILDIRQGPKEPFRDYV DRFYKTLRAEQASQEVKNRTTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPG HKARVLAEAMSQVTNSATIMMQRGNFRNQRKIIKCFNCGKEGHIAKNCRAPRKRGCWKCG KEGHQMKDCTERQANFLREDLAFLQGKAEFSSEQNRANSPTRRELQVWGRDNNSLSEAGE EAGDDRQGPVSFSFPQITLWQRPIVTIKIGGQLKEALLDTGADDTVLGEMNLPRRWKPKM IGGIGGFIKVRQYDQITIGICGHKAIGTVLVGPTPVNIIGRNLLTQLGCTLNFPISPIET VPVKLKPGMDGPKVKQWPLTEEKIKALIEICTEMEKEGKISKIGPENPYNTPVFAIKKKD STKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKY TAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDL YVGSDLEIGQHRAKIEELRRHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLP EKDSWTVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGTKALTEVIPLTEEAELELAENR EILKEPVHGVYYDPSKDLIAEVQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQ LTEAVQKIATESIVIWGKTPKFRLPIQKETWETWWTEYTXATWIPEWEVVNTPPLVKLWY QLEKEPIVGAETFYVDGAANRETKKGKAGYVTNRGRQKVVSLTDTTNQKTELQAIHLALQ DSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQ VDKLVSAGIRKVLFLDGIDKAQEDHEKYHSNWRAMASDFNLPPIVAKEIVASCDKCQLKG EAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGR WPVKTIHTDNGPNFTSTTVKAACWWTGIKQEFGIPYNPQSQGVIESMNKELKKIIGQVRD QAEHLKRAVQMAVFIHNFKRKGGIGGYSAGERIVGIIATDIQTKELQKQITKIQNFRVYY RDSRDPLWKGPAKLLWKGEGAVVIQDNNDIKVVPRRKAKVIRDYGKQTAGDDCVASRQDE D >Q9QBZ5|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype F2 (isolate MP255)|Swiss-Prot MGARASVLSGGKLDAWEKIRLKPGGKKRYRLKHLVWASRELERFALNPSLLETTEGCKKI IGQLQSSLQTGSEELKSLYNAVVVLYYVHQRIDVRDTKEALDKLQEEQDKSQQKEQQKAA DKEVSQNYPIVQNIQGQMVHQALSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGATPQDL NTMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPIPPGQMREPRGSDIAGTTSTLQ EQITWMTGNPPVPVGEIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVDRFFKTL RAEQATQEVKNWMTETLLVQNSNPDCKTILKALGPGATLEEMMTACQGVGGPGHKARILA EAMSKATSTAIMMQKSNFKGQKRIVKCFNCGKEGHIARNCRAPRKKGCWKCGKEGHQMKD CTERQANFFRENLAFQQGEARKFSSEQTRANSPASRELRVRRGDNPLPEAGAERRGTGSS LSFPQITLWQRPLVAIRVGGQLREALLDTGADDTVLEDINLPGKWKPKMIGGIGGFIKVR QYDQIPIEICGQKAIGTVLVGPTPVNIIGRNLLTQLGCTLNFPISPIETVPVKLKPGMDG PRVKQWPLTEEKIKALTEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFR ELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKEFRKYTAFTIPSINNE TPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRAKNPEIVIYQYMDDLYVGSDLEIGQH RTKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKSSWTVNDIQ KLVGKLNWASQIYPGIRIKHLCRLLRGAKALTDVVPLTAEAELELAENREIIKEPVHGVY YDPSKDLIAEIQKQGHDQWTYQIYQEPYKNLKTGKYAKRKSAHTNDVKQLTEVVQKIATE SIVIWGKIPKFRLPIQKETWEIWWTEYWQATWIPEWEFVNTPPLVKLWYQLETEPIAGAE TFYVDGAANRETKLGKAGYVTDRGRQKVVPLTETTNQKTELQAIHLALQDSGSEVNIVTD SQYALGIIQAQPDKSESELVNQIIEQLIQKEKVYLSWVPAHKGIGGNEQVDKLVSSGIRK VLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPVVAKEIVANCDKCQLKGEAMHGQVDCSP GIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKIIHTDNG SNFTSTVVKAACWWAGIQQEFGVPYNPQSQGVVESMNKELKKIIGQIRDQAEHLKTAVQM AVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQITKIQNFRVYFRDSRDPVWKGP AKLLWKGEGAVVIQDNNEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >Q79666|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group O (isolate MVP5180)|Swiss-Prot MGARASVLTGSKLDAWERIRLRPGSKKAYRLKHLVWASRELERYACNPGLLETAEGTEQL LQQLEPALKTGSEDLKSLWNAIAVLWCVHNRFDIRDTQQAIQKLKEVMASRKSAEAAKEE TSPRQTSQNYPIVTNAQGQMVHQAISPRTLNAWVKAVEEKAFNPEIIPMFMALSEGAVPY DINTMLNAIGGHQGALQVLKEVINEEAAEWDRTHPPAMGPLPPGQIREPTGSDIAGTTST QQEQIIWTTRGANSIPVGDIYRKWIVLGLNKMVKMYSPVSILDIRQGPKEPFRDYVDRFY KTLRAEQATQEVKNWMTETLLVQNSNPDCKQILKALGPEATLEEMMVACQGVGGPTHKAK ILAEAMASAQQDLKGGYTAVFMQRGQNPNRKGPIKCFNCGKEGHIAKNCRAPRKRGCWKC GQEGHQMKDCKNGRQANFFREVLASGGHEARQLCAETSVPISPTNGGGSEGTRESESEGG SGRAVPICLPQIPLWDRPIVTAKVGGHLCEALLDTGADDTVLNNIQLEGRWTPKMIGGIG GFIKVKEYNNVTVEVQGKEVQGTVLVGPTPVNILGRNILTGLGCTLNFPISPIAPVPVKL KPGMDGPKVKQWPLSREKIEALTAICQEMEQEGKISRIGPENPYNTPIFAIKKKDSTKWR KLVDFRELNKRTQDFWEVQLGIPHPGGLKQRQSVTVLDVGDAYFSCPLDPDFRKYTAFTI PSVNNETPGVRYQYNVLPQGWKGSPAIFQSSMTKILDPFRKSNPEVEIYQYIDDLYVGSD LPLAEHRKRVELLREHLYQWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPDKEVW TVNDIQKLVGKLNWASQIYQGIRVKELCKLIRGTKSLTEVVPLSKEAELELEENREKLKE PVHGVYYQPDKDLWVSIQKHGEGQWTYQVYQDEHKNLKTGKYARQKASHTNDIRQLAEVV QKVSQEAIVIWGKLPKFRLPVTRETWETWWAEYWQATWIPEWEFVSTPPLIKLWYQLETE PIVGAETFYVDGAANRNTKLGKAGYVTEQGKQNIIKLEETTNQKAELMAVLIALQDSKEQ VNIVTDSQYVLGIISSQPTQSDSPIVQQIIEELTKKERVYLTWVPAHKGIGGNEKIDKLV SKDIRRVLFLEGIDQAQEDHEKYHSNWRALASDFGLPPIVAKEIIASCPKCHIKGEATHG QVDYSPEIWQMDCTHLEGKIIIVAVHVASDFIEAEVIPAETGQETAYFLLKLAARWPVKV IHTDNGPNFTSAAMKAACWWTGIQHEFGIPYNPQSQGVVEAMNKELKSIIQQVRDQAEHL KTAVQMAVFVHNFKRKGGIGGYTAGERLIDILASQIQTTELQKQILKINNFRVYYRDSRD PIWKGPAQLLWKGEGAVVIQDKGDIKVVPRRKAKIIRDYGKQMAGTDSMANRQTESESME QPGEIP >P12497|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate NY5)|Swiss-Prot MGARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTIAVLYCVHQRIDVKDTKEALDKIEEEQNKSKKKAQQAAA DTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGKEG HQMKDCTERQANFLREDLAFPQGKAREFSSEQTRANSPTRRELQVWGRDNNSLSEAGADR QGTVSFSFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGG FIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDL EIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT VNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQ KIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEP IIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEV NIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDGLVS AGIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTV HTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVIESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDP VWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >P18802|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype D (isolate NDK)|Swiss-Prot MGARASVLSGGKLDTWERIRLRPGGKKKYALKHLIWASRELERFTLNPGLLETSEGCKQI IGQLQPSIQTGSEEIRSLYNTVATLYCVHERIEVKDTKEAVEKMEEEQNKSKKKTQQAAA DSSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVIEEKAFSPEVIPMFSALSEGATPQD LNTMLNTVGGHQAAMQMLKETINDEAAEWDRLHPVHAGPVAPGQMREPRGSDIAGTTSTL QEQIAWMTSNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRFYKT LRAEQASQDVKNWMTETLLVQNANPDCKTILKALGPQATLEEMMTACQGVGGPGHKARVL AEAMSQVTGSATAVMMQRGNFKGPRKSIKCFNCGKEGHTAKNCRAPRKKGCWKCGREGHQ MKDCTERQANFLREDLAFPQGKAGEFSSEQTRANSPTSRELRVWGGDNPLSETGAERQGT VSFSFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEINLPGKWKPKMIGGIGGFIK VRQYDQILIEICGYKAMGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLKPGM DGPKVKQWPLTEEKIKALTEICTEMEKEGKISRIGPENPYNTPIFAIKKKDSTKWRKLVD FRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSIN NETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEIVIYQYMDDLYVGSDLEIG QHRTKIEELREHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPINLPEKESWTVND IQKLVGKLNWASQIYAGIKVKQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHG VYYDPSKDLIAELQKQGDGQWTYQIYQEPFKNLKTGKYARTRGAHTNDVKQLTEAVQKIA TESIVIWGKTPKFKLPIQKETWETWWIEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIG AETFYVDGAANRETKLGKAGYVTDRGRQKVVPFTDTTNQKTELQAINLALQDSGLEVNIV TDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSQGI RKVLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDC SPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKVVHTD NGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAV QMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTRELQKQIIKIQNFRVYYRDSRDPIWK GPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED >P20892|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate OYI)|Swiss-Prot MGARASVLSGGELDKWEKIRLRPGGKKKYQLKHIVWASRELERFAINPGLLETSEGCRQI LGQLQPSLKTGSEEIRSLYNTVATLYCVHQKIEVKDTKEALDKIEEEQNKSKKKAQQTAA DTGNSSQVSQNYPIVQNLQGQMVHQPISPRTLNAWVKVVEEKAFSPEVIPMFSALAEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQDVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVNSVTVMMQKGNFKNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGREGH QMKDCTERQANFLREDLAFPQGKAREFSSEQTRANSPTSRELRVWGRDNNSPSEAGADRQ GTVSFNLPQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGF IKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQLGCTLNFPISPIETVPVKLKP GMDGPKVKQWPLTEEKIKVLIEICTEMEKEGKISKVGPENPYNTPVFAIKKKDSTKWRKL VDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPS INNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLE IGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIMLPEKDSWTV NDIQKLVGKLNWASQIYAGIKVKNLCKLLRGTKALTEVIPLTEEAELELAENREILKEPV HGVYYDPSKDLVAELQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQK ITQESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKDPI VGAETFYVDGAANRETKLGKAGYVTDRGRQKVVSLTDTTNQKTELQAIHLALQDSGLEVN IVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSA GIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQV DCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKTIH TDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNNELKKIIGQVRDQAEHLKT AVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSREPL WKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >P05959|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate RF/HAT3)|Swiss-Prot MGARASVLSGGKLDKWEKIRLRPRGKKRYKLKHIVWASRELERFAVNPSLLETAEGCRQI LGQLQPALQTGSEELKSLYNAVATLYCVHQNIEVRDTKEALDKIEEEQNKSKKKAQQAAA DTGNGSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPISILDIRQGPKEPFRDYVDRF YKTLRAEQASQDVKNWMTETFLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPSHKA RILAEAMSQVTNSATIMLQKGNFRDQRKIVKCFNCGKVGHIAKNCRAPRKKGCWKCGKEG HQMKDCTNEGRQANFLRENLAFPQGKARELSSEQTRANSPTRRELQVWGRDNSLSEAGED RQGTVSFSFPQITLWQRPIVTVKIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIG GFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKL KPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWR KLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKEFRKYTAFTI PSINNETPRIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPEIVIYQYMDDLYVGSD LEIGQHRIKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSW TVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGTKALTEVVQLTKEAELELAENREILKE PVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAV QKVATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKE PIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVSLTDTTNQKTELQAIHLALQDSGLE VNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDRLV STGIRKVLFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHG QVDCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKV IHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKQLKQIIGQVRDQAEHL KTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRD PLWKGHAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >Q9WC54|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype J (isolate SE9280)|Swiss-Prot MGARASILSGGKLDDWEKIRLRPGGKKKYRIKHLVWASRELDRFALNPGLLESAKGCQQI LVQLQPALQTGTQEIKSLYNTVATLYCVHQRIEIKDTMEALEKIEEIQNKNKQQAQKAET DKKDNSQVSQNYPIVQNLQGQPVHQALSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTIGGHQAAMQMLKDTINEEAAEWDRVHPVHAGPIAPGQVREPRGSDIAGTT STLQEQIGWMTGNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRF FKALRAEQATQDVKNWMTDTLLVQNANPDCKTILKALGSGATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNTNIMMQRGNFRDHKRIVKCFNCGKQGHIAKNCRAPRKKGCWKCGKEGH QMKDCTERQANFFREDLAFQQREARELSPEQTRANSPTSREPRARRGDPLPETGAEGQGT VSSNFPQITLWQRPLVTIRIGGQLREALLDTGADDTVLEDIDLPRKWKPKMIGGIGGFIK VRQYNEVPIEIEGKKAIGTVLIGPTPVNIIGRNMLTQLGCTLNFPISPIETVPVKLKPGM DGPKIKQWPLTEEKIKALTQICAEMEEEGKISRVGPENPYNTPVFAIKKKDSTKWRKLVD FRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLYEDFRKYTAFTIPSIN NETPGIRYQYNVLPQGWKGSPAIFQCSMTKILKPFRERNPEIVIYQYMDDLYVGSDLEIE QHRRKIKELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKEDWTVND IQKLVGKLNWASQIYPGIKVKQLCKLLKGAKALTDIVPLTREAELELAENKEILKEPVHG VYYDSAKELIAEVQKQGLDQWTYQIYQEPFKNLKTGKYAKRRSAHTNDVKQLAEVVQKIA LEAIVIWGKTPKFRLPIQRETWETWWTDYWQATWIPEWEFVNTPPLVKLWYQLEKEPIMG AETFYVDGASNRETKTGKAGYVTDKGRQKVVTLTDTTNQKTELHAIYLALRDSGLEVNIV TDSQYALGIIQAQPDKSESELVNQIIEELIKKEKVYLSWVPAHKGIGGNEQVDKLVSSGI RKVLFLDGIDKAQEDHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDC SPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQEAAFFILKLAGRWPVKVIHTD NGSNFTSGAVKAACWWADIKQEFGIPYNPQSQGVVESMNKELKKIIGQVREQAEHLKTAV QMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTRELQKQITKIQNFRVYYRDSRDPIWK GPAKLPWKGEGAVVIQDNSEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >Q9WC63|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype J (isolate SE9173)|Swiss-Prot MGARASILSGGKLDDWEKIRLRPGGKKQYRIKHLVWASRELDRFALNPGLLESAKGCQQI LVQLQPALQTGTEEIKSLYNTVATLYCVHQRIEIKDTKEALDKIEEIQNKNKQQTQKAET DKKDNSQVSQNYPIVQNLQGQPVHQALSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTIGGHQAAMQMLKDTINEEAAEWDRVHPVHAGPVAPGQVREPRGSDIAGTT SNLQEQIGWMTGNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRF FKALRAEQATQDVKNWMTDTLLVQNANPDCKTILKALGSGATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNTNIMMQRGNFRDHKRIVKCFNCGKQGHIAKNCRAPRKKGCWKCGKEGH QMKDCTERQANFFREDLAFQQREAREFSPEQTRANSPTSREPRVRRGDPLPETGAEGQGT VSSNFPQITLWQRPLVTIRIGGQLREALLDTGADDTVLEEIDLPGKWKPKMIGGIGGFIK VRQYNEVPIEIEGKKAIGTVLIGPTPVNIIGRNMLTQLGCTLNFPISPIETVPVKLKPGM DGPKIKQWPLTEEKIKALTQICAELEEEGKISRIGPENPYNTPVFAIKKKDSTKWRKLVD FRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLYEDFRKYTAFTIPSIN NETPGIRYQYNVLPQGWKGSPAIFQCSMTKILKPFRERNPEIVIYQYMDDLYVGSDLEIE QHRRKIKELREHLLKWGFYTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKEDWTVND IQKLVGKLNWASQIYPGIKIKELCKLIRGAKALTDIVPLTREAELELAENKEILKEPVHG VYYDPARELIAEVQKQGLDQWTYQIYQEPFKNLKTGKYAKRRSAHTNDVKQLSQVVQKIA LEAIVIWGKTPKFRLPIQKETWETWWTDYWQATWIPEWEFVNTPPLVKLWYQLEKEPIMG AETFYVDGASNRETKVGKAGYVTDKGRQKVITLTDTTNQKTELQAIYLALQDSGIEVNIV TDSQYALGIIQAQPDKSESELVNQIIEELIKKEKVYLSWVPAHKGIGGNEQVDKLVSSGI RKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDC SPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQEAAFFILKLAGGWPVKAIHTD NGSNFTSGAVKAACWWADIKQEFGIPYNPQSQGVVESMNKELKKIIGQVREQAEHLKTAV QMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQITKIQNFRVYYRDSRDPIWK GPAKLLWKGEGAVVIQDNSEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >O89940|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype G (isolate SE6165)|Swiss-Prot MGARASVLTGGKLDAWEKIRLRPGGRKSYKIKHLVWASRELERFALNPDLLETAEGCQQI MRQLQPSLQTGTEEIKSLYNAVATLYCVHQRIEVKDTKEALEEVEKIQKKSQEKIQQAAM DKGNSNQVSQNYPIVQNAQGQMVHQAITPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNLMLNTVGGHQAAMQMLKDTINEEAAEWDRMHPQQAGPFPPGQIREPRGSDIAGTT SSLQEQITWMTGNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRF FKCLRAEQASQDVKGWMTDTLLVQNANPDCKTILRALGQGASLEEMMTACQGVGGPSHKA RVLAEAMSQASGAAAAIMMQRSNFKGPRRTIKCFNCGKEGHLARNCRAPRKKGCWKCGKE GHQMKDCTERQANFFRENLAFQQGEAREFSSEQDRTNSPTCRKPRVRRGDSPLPEAGDEG KGAISLPQITLWQRPLVTVKIGGQLIEALLDTGADDTVLEEINLPGRWKPKMIGGIGGFI KVRQYDQVPIEISGKKAIGTILVGPTPINIIGRNMLTQIGCTLNFPISPIETVPVKLKPG MDGPRVKQWPLTEEKIKALTEICKEMEEEGKISKIGPENPYNTPIFAIKKKDSTKWRKLV DFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSI NNETPGVRYQYNVLPQGWKGSPAIFQSSMTRILEPFRANNPEMVIYQYMDDLYVGSDLEI GQHRAKIEELREHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPDKESWTVN DIQKLVGKLNWASQIYPGIKVTHLCKLLRGAKALTDIVSLTAEAEMELAENREILREPVH GVYYDPSKELIAEVQKQGLDQWTYQIYQEPYKNLKTGKYAKRGSAHTNDVKQLTEVVQKI ATESIVIWGKTPKFKLPIRKETWEIWWTDYWQATWIPEWEFVNTPPLVKLWYRLETEPIP GAETYYVDGAANRETKLGKAGYVTDKGKQKIITLTETTNQKAELQAIQLALQDSRSEVNI VTDSQYALGIIQAQPDRSEAELVNQIIEQLIKKEKVYLSWVPAHKGIGGNEQVDKLVSSG IRKVLFLDGIDKAQEEHERYHNNWRAMASDFNLPPIVAKEIVASCDKCQLKGEAMHGQVD CSPGIWQLDCTHLEGKIIIVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVTVIHT DNGSNFTSAAVKAACWWANITQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTA VQMAVFIHNFKRKGGIGGYSAGERIIDIIASDIQTKELQKQITKIQNFRVYYRDSRDPVW KGPAKLLWKGEGAVVIQDNNEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >P24740|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype A (isolate U455)|Swiss-Prot MGARASVLSGKKLDSWEKIRLRPGGNKKYRLKHLVWASRELEKFTLNPGLLETAEGCQQI LGQLQPALQTGTEELRSLYNTVAVLYCVHQRIDVKDTKEALNKIEEMQNKNKQRTQQAAA NTGSSQNYPIVQNAQGQPVHQALSPRTLNAWVKVVEDKAFSPEVIPMFSALSEGATPQDL NMMLNVVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPIPPGQMREPRGSDIAGTTSTVQ EQIGWMTGNPPIPVGDIYRRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDRFFKTL RAEQATQDVKNWMTETLLVQNANPDCKSILRALGPGATLEEMMTACQGVGGPGHKARVLA EAMSQVQQTSIMMQRGNFRGPRRIKCFNCGKEGHLAKNCRAPRKKGCWKCGKEGHQMKDC TERQANFLRENLAFQQGEAREFSSEQTRANSPTSRNLWDGGKDDLPCETGAERQGTDSFS FPQITLWQRPLVTVKIGGQLIEALLDTGADDTVLEDINLPGKWKPKIIGGIGGFIKVRQY DQILIEICGKKTIGTVLVGPTPVNIIGRNMLTQIGCTLNFPISPIETVPVKLKPEMDGPK VKQWPLTEEKIKALTEICNEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFREL NKRTQDFWEVQLGIPHTAGLKKKKSVTVLDVGDAYFSVPLDESFRKYTAFTIPSINNETP GVRYQYNVLPQGWKGSPSIFQSSMTKILEPFRSQHPDIVIYQYMDDLYVGSDLEIGQHRA KIEELRAHLLSWGFITPDKKHQKEPPFLWMGYELHPDKWTVQPIQLPEKDSWTVNDIQKL VGKLNWASQIYAGIKVKQLCKLLRGAKALTDIVTLTEEAELELAENREILKDPVHGVYYD PSKDLVAEIQKQGQDQWTYQIYQEPFKNLKTGKYARKRSAHTNDVKQLTEVVQKVSTESI VIWGKIPKFRLPIQKETWEAWWMEYWQATWIPEWEFVNTPPLVKLWYQLEKDPIAGAETF YVDGAANRETKLGKAGYVTDRGRQKVVSLTETTNQKTELHAIHLALQDSGSEVNIVTDSQ YALGIIQAQPDRSESEIVNQIIEKLIEKEKVYLSWVPAHKGIGGNEQVDKLVSSGIRKVL FLDGIDKAQEDHEKYHCNWRAMASDFNLPPVVAKEIVASCNKCQLKGEAMHGQVDCSPGI WQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKVIHTDNGSN FTSAAVKAVCWWANIQQEFGIPYNPQSQGVVESMNKELKKIIGQVREQAEHLKTAVQMAV FIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQISKIQNFRVYYRDSRDPIWKGPAK LLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCMAGRQDED >Q9Q720|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype H (isolate VI991)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGRKKYRLKHLVWASRELERFALNPDLLETADGCQQI LGQLQPALKTGTEDLQSLYNTIAVLYCVHQRIDVKDTKEALGKIEEIQNKNKQRTQQAPA AADKEKDSKISQNYPIVQNAQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEG ATPQDLNAMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPIPPGQMREPRGSDIAG TTSTLQEQVAWMTGNPPIPVGDIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVD RFFRVLRAEQATQDVKNWMTDTLLVQNANPDCRTILKALGRGASIEEMMTACQGVGGPSH KARVLAEAMSQVTNASAAIMMQKGNFKGPRRTVKCSNCGKEGHIARNCRAPRKKGCWKCG QEGHQMKDCTGRQANFFRENLAFQQGKAREFPPEEARANSPTSRELRVRRGDHPLSEAGA ERTGTSFNFPQITLWQRPIVTVKIEGQLKEALLDTGADDTVLEDINLPGKWKPKMIGGIG GFIKVRQYEQVAIEIFGKKAIGTVLVGPTPVNIIGRNILTQMGCTLNLPISPIETVPVTL KPGMDGPKVKQWPLTEEKIKALTEICLEMEKEGKISKIGPENPYNTPIFAIKKKNSTRWR KLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVSVLDVGGAYFSVPLHEDFRKYTAFTI PSTNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEVIIYQYMDDLYVGSD LEIGQHREKIEELRAHLLRWGFTTPDQKHQKEPPFLWMGYELHPDKWTVQPVKLPEKDSW TVNDIQKLVGKLNWASQIYPGIKVKQLCXLLRGAKALTEIVPLTKEAELELAENREILKE PVHGAYYDPSKELIAEIQKQGPDQWTYQIYQEPFKNLKTGKYAKMRSAHTNDVKQLTEVV QKIATESIVIWGKIPKFRLPIQKETWETWWTEHWQATWIPEWEFVNTPHLVKLWYQLETE PIEGAETYYVDGAANRETKMGKAGYVTDRGKQKIVSLTETTNQKTELQAIYLALQESGPE VNIVTDSQYALGIIQAQPDKSESELVNQIIEELIKKEKFYLSWVPAHKGIGGNEQVDKLV SSGIRKVLFLDGIDKAQVQHEKYHSNWRAMASDFNLPPIVAKEIVASCDKCQLKGEAMHG QVDCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKM IHTDNGSNFTSAAVKAACWWADIHQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHL RTAVQMAVFIHNFKRKGGIGGYSARERIIDIIATDIPTKELQKQISQIQKFRVYYRDSRD PIWKGPAKLLWKGEGAVVIQDNSEIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >Q9QSR3|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype F1 (isolate VI850)|Swiss-Prot MGARASILSGGKLDEWEKIQLRPGGKKRYKMKHLIWASRELERFALDPGLLETSEGCQKI IRQLQPSLQTGSEELKSLFNTVAVLYYVHQRAGVTDTKEALDKLEEEQNKSQQKTQQAAA DKGVSQNYPIVQNLQGQMVHQSLSPRTLNAWVKVIEEKAFSPEVIPMFSALSEGATPTDL NTMLNTVGGHQAAMQMLKDTINEEAAEWDRLHPVHAGPAPPGQMREPRGSDIAGTTSTLQ EQIQWMTGNPPVPVGDIYKRWIILGLNKIVRMYSPVSILDIKQGPKEPFRDYVDRFFKVL RAEQASQDVKGWMTDTLLVQNANPDCKTILKALGTGATLEEMMTACQGVGGPSHKARVLA EAMSQANSAIMMQKSNFKGQRRVVKCFNCGKEGHIARNCRAPRKKGCWKCGREGHQMKDC TERQANFFRENLAFQQGEARKFPSEQTRANSPTSRELRVQRGDNPLSEAGAERRGTVPSL SFPQITLWQRPLVTIKIGGQIKEALLDTGADDTVLEDINLPGKWKPKMIGGIGGFIKVKQ YDNILIEICGHKAIGTVLVGPTPVNIIGRNMLTQIGCTLNFPVSPIETVPVKLKPGMDGP KVKQWPLTEEKIKALTEICLEMEKEGKISKIGPENPYNTPVFAIKKKDSSKWRKLVDFKE LNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFKKYTAFTIPSVNNET PGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRMKNPDIVIYQYMDDLYVGSDLEIGQHR TKIEELREHLLRWGFTTPDKKHQKEPPFLWMGHELHPDKWTVQPIQLPNKDSWTVNDIQK LVGKLNWASQIYPGIKVRPLCKLLRGAKALTDIVPLTAEAELELAKNREILREPVHGVYY DPSKDLIAEIQKQGDGQWTYQIYQNPFKNLKTGKYAKVRSAHTNDVKQLTEAVQKIALES IVIWGKRSPKFKLPILKETWDTWWTDYWQATWIPEWEFVNTPPLVKLWYQLETEPIAGAD TFYVDGASNRETKKGKAGYVTDKGKQKVVSLTETTNQKAELQAIYLALQDSGSEVNIVTD SQYALGIIQAQPDKSESEIVNQIIEQLIQKERVYLSWVPAHKGIGGNEQVDKLVSAGVRK ILFLDGIDKAQEEHEKYHNNWRAMASDFNLPPIVAKEIVASCDKCQLKGEAMHGQVDCSP GIWQLDCTHLEGKVILVAVHVASEYIEAEVIPAETGQETAYFILKLAGRWPVKIIHTDNG SNFTSAAVKASCWWAGIQQEFGIPYNPQSQGVVESINKELKKIIGQVRDQAEHLKTAVQM AVFIHNFKRKGGIGGYSAGERIIDIISTDIQTRELQKQITKIQNFRVYYRDSRNPVWKGP AKLLWKGEGAVVIQDNSEIKIVPRRKAKIIRDYGKQMAVDDCVAGRQDED >P35963|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate YU-2)|Swiss-Prot MGARASVLSAGELDKWEKIRLRPGGKKQYRLKHIVWASRELERFAVDPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQKIEVKDTKEALEKIEEEQNKSKKKAQQAAA DTGNSSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSATIMMQRGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGKEG HQMKDCTERQANFLREDLAFPQGKARKFSSEQTRANSPIRRERQVWRRDNNSLSEAGADR QGTVSFSFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGG FIKVRQYDQIPIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLHEDFRKYTAFTIP SINNETPGTRYQYNVLPQGWKGSPAIFQSSMTTILEPFRKQNPDLVIYQYMDDLYVGSDL EIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT VNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARTRGAHTNDVKQLTEAVQ KIATESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEP IIGAETFYVDGAANRETKLGKAGYVTNKGRQKVVSLTDTTNQKTELQAIYLALQDSGLEV NIVTDSQYALGIIQAQPDRSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS AGIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVTTI HTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVAGRQDED >Q9IDV9|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group N (isolate YBF106)|Swiss-Prot MGARASVLTGGKLDQWEAIYLRPGGKKKYRLKHLVWASRELERFACNPGLMDTANGCAQL INQLEPALKTGSEGLRSLXNTLAVLYCVHSNIPVHNTQEALDKIKEKQEQHKSEPKKPEA GTAAAADSSISRNYPLVQNAQGQMVHQPLTPRTLNAWVKVIEEKAFNPEIIPMFMALSEG ATPSDLNSMLNTVGGHQAAMQMLKEVINEEAAEWDRTHPAPVGPLPPGQMRDPRGSDIAG TTSTLAEQVAWMTSNPPIPVGDIYRRWIVLGLNRIVRMYSPVSILEIKQGPKEPFRDYVD RFYKTLRAEQATQDVKNWMTETLLVQNANPDCKQILKALGPGATLEEMMTACQGVGGPAH KARVLAEAMAQAQTATSVFVQRGNFKGIRKTIKCFNCGKEGHLARNCKAPRRRGCWKCGQ EGHQMKDCKNEGXQANFRKGLVSLQRETRKLPPDNNKERAHSPATRELWVSGGEEHTGKG DAGEPGEDRDLSVPTLNFPQITLWQRPVXAVKIGKEIREALLDTGADDTVIEEIQLEGKW KPKMIGGIGGFIKVRQYDNITIDIQGRKAVGTVLVGPTPVNIIGRNFLTQIGCTLNFPIS PIETVPVKLKPGMDGPRVKQWPLTAEKIEALREICTEMEKEGKISRIGPENPYNTPIFAI KKKDSTKWRKLVDFRELNKRTQEFWEVQLGIPHPAGLKQKKSVTVXDVGDAYFSCPLDKD FRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKKHPEIIIYQY MDDLYVGSDLEIAQHRETVEELRGHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQP IKLPEKEVWTVNDIQKLVGKLNWASQIYPGIKVKQLCKLIRGTKALTEVVTFTQEAELEL AENREILKEPLHGVYYDPGKELIAEIQKQGQGQWTYQIYQEPYKNLKTGKYAKXRSAHTN DIKELAAVVQKVATESIVIWGKTPKFKLPVQKEVWETWWTEHWQATWIPEWEFVNTPPLV KLWYQLETEPISGAETYYVDGAANKETKLGKAGFVTDRGRQKVVSIENTTNQKAELQAIL LALQESGQEANIVTDSQYAMGIIHSQPDKSESDLVGQIIEELIKKERVYLSWVPAHKGIG GNEQVDXLVSSGIRXVLFLDGIEKAQEEHERYHSNWKAMASDFNLPPIVAKEIVASCDKC QLKGEAMHGQINCSPGVWQLDCTHLEGKIILVAVHVASGYLEAEVIPAETGQETAYFILK LAGRWPVKVIHTDNGPNFISATVKAACWWAGIKQEFGIPYNPQSQGAVESMNKELKKIIG QIRDQAEHLKTAVQMAVFIHNFKRKGGIGGXTAGERIIDIIATDIQTTKLQTQILKVQNF XVYYRDSRDPIWKGPAKLLWKGEGAVVIQDNGDIKVVPRRKAKIIRDYGKQMAGDGCVAS GQDENQDME >O91080|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group N (isolate YBF30)|Swiss-Prot MGARASVLTGGKLDQWESIYLRPGGKKKYRMKHLVWASRELERFACNPGLMDTADGCAKL LNQLEPALKTGSEELRSLYNALAVLYCVHSRIQIHNTQEALDKIKEKQEQHKPEPKNPEA GAAAATDSNISRNYPLVQTAQGQMVHQPLTPRTLNAWVKVIEEKAFSPEVIPMFMALSEG ATPSDLNTMLNTVGGHQAAMQMLKEVINEEAADWDRTHPVPVGPLPPGQLRDPRGSDIAG TTSTLAEQVAWMTANPPVPVGDIYRRWIVLGLNRIVRMYSPVSILEIKQGPKEPFRDYVD RFYKTLRAEQATQEVKNWMTETLLVQNANPDCKQLLKALGPGATLEEMMTACQGVGGPAH KARVLAEAMSQVQQPTTSVFAQRGNFKGIRKPIKCFNCGKEGHLARNCKAPRRGGCWKCG QEGHQMKDCKNEGRQFFREELVSLQRETRKLPPDNNKERAHSPATRELWVSGGEEHTGEG DAGEPGEDRELSVPTFNFPQITLWQRPVITVKIGKEVREALLDTGADDTVIEELQLEGKW KPKMIGGIGGFIKVRQYDNITVDIQGRKAVGTVLVGPTPVNIIGRNLLTQIGCTLNFPIS PIETVPVKLKPGMDGPKVKQWPLTTEKIEALREICTEMEKEGKISRIGPENPYNTPIFAI KKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSCPLDKD FRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSTMTKILEPFREKHPEIIIYQY MDDLYVGSDLELAQHREAVEDLRDHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQP IKLPEKDVWTVNDIQKLVGKLNWASQIYPGIRVKQLCKLIRGTKALTEVVNFTEEAELEL AENREILKEPLHGVYYDPGKELVAEIQKQGQGQWTYQIYQELHKNLKTGKYAKMRSAHTN DIKQLVEVVRKVATESIVIWGKTPKFRLPVQKEVWEAWWTDHWQATWIPEWEFVNTPPLV KLWYQLETEPISGAETFYVDGAANRETKLGKAGFVTDRGRQKVVSIADTTNQKAELQAIL MALQESGRDVNIVTDSQYAMGIIHSQPDKSESELVSQIIEELIKKERVYLSWVPAHKGIG GNEQVDKLVSSGIRKILFLDGIEKAQEDHDRYHSNWKAMASDFNLPPIVAKEIVASCDKC QLKGEAMHGQVNCSPGVWQLDCTHLEGKIILVAVHVASGYLEAEVIPAETGQETAYFILK LAGRWPVKVIHTDNGSNFTSATVKAACWWANIKQEFGIPYNPQSQGAVESMNKELKKIIG QIRDQAEHLKTAVQMAVFIHNFKRKGGIGGYTAGERIIDIIATDIQTTNLQTQILKVQNF RVYYRDSRDPIWKGPAKLLWKGEGAVVIQDNGDIKVVPRRKAKIIRDYGKQMAGDGCVAS GQDENQEME >P12499|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype D (isolate Z2/CDC-Z34)|Swiss-Prot MGARASVLSGGKLDAWEKIRLRPGGKKKYRLKHLVWASRELERFALNPGLLETSDGCKQI IGQLQPAIRTGSEELRSLFNTVATLYCVHERIEVKDTKEALEKMEEEQNKSKNKKAQQAA ADAGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVIEEKAFSPEVIPMFSALSEGA TPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGT TSTLQEQIAWMTSNPPIPVGEIYKRWIILGLNKIVRMYSPVSILDIRQGPKEPFRDYVDR FYKTLRAEQASQEVKGWMTETLLVQNANPDCKTILKALGPQATLEEMMTACQGVGGPSHK ARVLAEAMSQATNSAAAVMMQRGNFKGPRKTIKCFNCGKEGHIAKNCRAPRRKGCWKCGK EGHQLKDCTERQANFLREDLAFPQGKAGELSSEQTRANSPTSRELRVWGRDNPLSETGAE RQGTVSFNCPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIG GFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKL KPGMDGPKVKQWPLTEEKIKALTEICTEMEKEGKISRVGPENPYNTPIFAIKKKDSTKWR KLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTI PSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEIVIYQYMDDLYVGSD LEIGQHRTKIEELREHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQSIKLPEKESW TVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKE PVHGVYYDPSKDLIAEIQKQGHGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLAEVV QKISTESIVIWGKTPKFRLPIQKETWETWWVEYWQATWIPEWEFVNTPPLVKLWYQLEKE PIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPFTDTTNQKTELQAINLALQDSGLE VNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLV SQGIRKVLFLDGIDKAQEEHEKYHNNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHG QVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVKI VHTDNGSNFTSAAVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHL KTAVQMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQITKIQNFRVYYRDSRD PIWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED >P18096|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate BEN)|Swiss-Prot MGARNSVLRGKKADELEKVRLRPGGKKKYRLKHIVWAANELDKFGLAESLLESKEGCQKI LRVLDPLVPTGSENLKSLFNTVCVIWCLHAEEKVKDTEEAKKLAQRHLVAETGTAEKMPN TSRPTAPPSGKRGNYPVQQAGGNYVHVPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAADWDSQHPIPGPLPAGQLRDPRGSDIAGT TSTVDEQIQWMYRPQNPVPVGNIYRRWIQIGLQKCVRKYNPTNILDIKQGPKEPFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPGQ KARLMAEALKEAMGPSPIPFAAAQQRKAIRYWNCGKEGHSARQCRAPRRQGCWKCGKPGH IMANCPERQAGFFRVGPTGKEASQLPRDPSPSGADTNSTSGRSSSGTVGEIYAAREKAEG AEGETIQRGDGGLAAPRAERDTSQRGDRGLAAPQFSLWKRPVVTAYIEDQPVEVLLDTGA DDSIVAGIELGDNYTPKIVGGIGGFINTKEYKNVEIKVLNKRVRATIMTGDTPINIFGRN ILTALGMSLNLPVAKIEPIKVTLKPGKDGPRLKQWPLTKEKIEALKEICEKMEKEGQLEE APPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEIQLGIPHPAGLAKKKRISIL DVGDAYFSIPLHEDFRQYTAFTLPAVNNMEPGKRYIYKVLPQGWKGSPAIFQYTMRQVLE PFRKANPDVILIQYMDDILIASDRTGLEHDKVVLQLKELLNGLGFSTPDEKFQKDPPFQW MGCELWPTKWKLQKLQLPQKDIWTVNDIQKLVGVLNWAAQIYSGIKTKHLCRLIRGKMTL TEEVQWTELAEAELEENKIILSQEQEGYYYQEEKELEATIQKSQGHQWTYKIHQEEKILK VGKYAKIKNTHTNGVRLLAQVVQKIGKEALVIWGRIPKFHLPVERETWEQWWDNYWQVTW IPEWDFVSTPPLVRLTFNLVGDPIPGAETFYTDGSCNRQSKEGKAGYVTDRGKDKVKVLE QTTNQQAELEVFRMALADSGPKVNIIVDSQYVMGIVAGQPTESENRIVNQIIEEMIKKEA VYVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSIIKELTHKFGIPL LVARQIVNSCAQCQQKGEAIHGQVNAEIGVWQMDYTHLEGKIIIVAVHVASGFIEAEVIP QESGRQTALFLLKLASRWPITHLHTDNGPNFTSQEVKMVAWWVGIEQSFGVPYNPQSQGV VEAMNHHLKNQISRIREQANTIETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQEI QFLQRKNSNFKNFQVYYREGRDQLWKGPGELLWKGEGAVIVKVGTDIKVVPRRKAKIIRD YGGRQELDSSPHLEGAREDGEMACPCQVPEIQNKRPRGGALCSPPQGGMGMVDLQQGNIP TTRKKSSRNTGILEPNTRKRMALLSCSKINLVYRKVLDRCYPRLCRHPNT >P24107|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate CAM2)|Swiss-Prot MGARNSVLRGKKADELEKVRLRPGGKKKYKLKHIVWAANELDRFGLAESLLESKEGCQRI LKVLDPLVPTGSENLKSLFNTVCVIWCIHAEEKVKDTEEAKRIALRHLAAETGTAEKMPD TSRPTAPPSGKGGNYPVQSIGGNYTHVPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAADWDANHPIPGPLPAGQLRDPRGSDIAGT TSTVEEQIQWMFRAQNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDIKQGPKESFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLVQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPGQ KARLMAEALKEAMGPPPIPFAAAQQRRTIKCWNCGKEGHSARQCRAPRRQGCWKCGKPGH IMTNCPDRQAGFLRDWPLGKEAPQFPRGPSSTGANTNSTPIGSSSGSTGEIYAAREKAEG AETETIQRGDRGLTAPRTRRGPMQGDNRGLAAPQFSLWKRPVVTAHIEGQPVEVLLDTGA DDSIVAGIELGSNYSPKIVGGIGGFINTKEYKNVEIEVLGKRVRATIMTGDTPINIFGRN ILTALGMSLNLPVAKIEPIKIMLKPGKDGPRLRQWPLTKEKIEALKEICEKMEKEGQLEE APPTNPYNTPTFAIRKKDKNKWRMLIDFRELNKVTQDFTEIQLGIPHPAGLAKKRRITVL DVGDAYFSIPLHEDFRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRQVLE PFRKANSDVIIIQYMDDILIASDRTDLEHDKVVLQLKELLNNLGFSTPDEKFQKDPPYRW MGYELWPTKWKLQKIQLPQKEVWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTL TEEVQWTELAEAELEENRIILSQEQEGHYYQEEKELEATVQKDQDNQWTYKIHQEEKILK VGKYAKIKHTHTNGVKLLAQVVQKIGKEALVIGRIPKFHLPVEREVWEQWWDNYWQVTWI PDWDFVSTPPLVRLAFNLVGDPIPGTETFYTDGSCNRQSKEGKAGYVTDRGRDKVKILEQ TTNQQAELEAFAMALTDSGPKANIIVDSQYVMGIVAGQPTESENRIVNQIIEEMIKKEAI YVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHTNVKELCHKFDIPQL VARQIVNTCAQYQQKGEAIHGQVNAEVGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIPQ ESGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWVGIEQTFGVPYNPQSQGVV EAMNHHLKNQISRIREQANTVETIVLMAVHCMNFKRRGGIGDMTPSERLINMITTEQEIQ FLQAKNSKLKNFRVYFREGRDQLWKGPGELLWKGDGAVIVKVGTDIKIIPRRKAKIIRDY GGRQELDSSSHLEGARENGEVA >P17757|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate D194)|Swiss-Prot MGARNSVLRGKKADELEKVRLRPNGKKRYRLKHVVWAANELDRFGLAESLLESKEGCQKI LKVLEPLVPTGSENLKSLFNTVCVIWCLHAEEKVKDTEEAKKLAQRHLVAETGTAEKMPN ISRPTAPPSGKGGNFPVQQAGGNYIHVPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAADWDAQHPIPGPLPAGQLRDPRGSDIAGT TSTVDEQIQWMYRQPNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDVKQGPKESFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPSQ KARLMAEALKEALTPAPIPFAAAQQRRAIRCWNCGKEGHSAKQCRAPRRQGCWKCGKSGH IMANCPERQAGFLDGPTGKAAPQLPRGPSSSGADTNSTPNRSSSGPVGEIYAAREKAERA EGETIQGGDGGLTAPRAGRDAPQRGDRGLATPQFSLWKRPVVTAFIEDQPVEVLLDTGAD DSIVAGIELGDNYTPKIVGGIGGFINTKEYKNVEIKVLNKRVRATIMTGDTPINIFGRNI LATLGMSLNLPVAKLDPIKVTLKPGKDGPRLKQWPLTKEKIEALKEICEKMEREGQLEEA PPTNPYNTPTFAIKKKDKNKWRMLIDFRELNRVTQDFTEIQLGIPHPAGLAKKKRITVLD VGDAYFSIPLHEDFRQYTAFTLPSVNNAEPEKRYVYKVLPQGWKGSPAIFQFMMRQILEP FRKANPDVILIQYMDDILIASDRTGLEHDKVVLQLKELLNGLGFSTPDEKFQKDPPFQWM GYELWPTKWKLQKIQLPQKEIWTVNDIQKLVGVLNWAAQIYPGIKTKHLCKLIRGKMTLT EEVQWTELAEAELEENKIILSQEQEGSYYQEEEELEATVIKSQDNQWAYKIHQGERVLKV GKYAKIKNTHTNGVRLLAQVVQKIGKEALVIWGRVPKFHLPVERDTWEQWWDNYWQVTWV PEWDFVSTPPLVRLTFNLVGDPIPGTETFYTDGSCNRQSKEGKAGYVTDRGRDRVRVLEQ TSNQQAELEAFAMALADSGPKVNIIVDSQYVMGIVAGQPTESENRIVNQIIEDMIKKEAV YVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNIKELTHKFGIPQL VARQIVNTCAQCQQKGEAIHGQVNAEIGVWQMDCTHLEGKIIIVAVHVASGFIEAEVIPQ ESGRQTALFLLKLASRWPITHLHTDNGPNFTSQEVKMVAWWIGIEQSFGVPYNPQSQGVV EAMNHHLKNQISRIREQANTIETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQEIQ FLQRKNSNFKKFQVYYREGRDQLWKGPGELLWKGDGAVIVKVGADIKVVPRRKAKIIRDY GGRQELDSSSHLEGAREDGEVA >P15833|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype B (isolate D205)|Swiss-Prot MGARGSVLSGKKTDELEKVRLRPGGKKKYMLKHVVWAVNELDRFGLAESLLESKEGCQKI LKVLAPLVPTGSENLKSLFNIVCVIFCLHAEEKVKDTEEAKKIAQRHLAADTEKMPATNK PTAPPSGGNYPVQQLAGNYVHLPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEGCTPYD INQMLNCVGEHQAAMQIIREIINEEAADWDQQHPSPGPMPAGQLRDPRGSDIAGTTSTVE EQIQWMYRAQNPVPVGNIYRRWIQLGLQKCVRMYNPTNILDIKQGPKEPFQSYVDRFYKS LRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGIGGPGQKARLM AEALKEALTPAPIPFAAVQQKAGKRGTVTCWNCGKQGHTARQCRAPRRQGCWKCGKTGHI MSKCPERQAGFLRVRTLGKEASQLPHDPSASGSDTICTPDEPSRGHDTSGGDTICAPCRS SSGDAEKLHADGETTEREPRETLQGGDRGFAAPQFSLWRRPVVKACIEGQSVEVLLDTGV DDSIVAGIELGSNYTPKIVGGIGGFINTKEYKDVEIEVVGKRVRATIMTGDTPINIFGRN ILNTLGMTLNFPVAKVEPVKVELKPGKDGPKIRQWPLSREKILALKEICEKMEKEGQLEE APPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEVNWVFPTRQVAEKRRITVID VGDAYFSIPLDPNFRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSQSICQYSMRKVLDP FRKANSDVIIIQYMDDILIASDRSDLEHDRVVSQLKELLNDMGFSTPEEKFQKDPPFKWM GYELWPKKWKLQKIQLPEKEVWTVNAIQKLVGVLNWAAQLFPGIKTRHICKLIRGKMTLT EEVQWTELAEAELQENKIILEQEQEGSYYKERVPLEATVQKNLANQWTYKIHQGNKVLKV GKYAKVKNTHTNGVRLLAHVVQKIGKEALVIWGEIPVFHLPVERETWDQWWTDYWQVTWI PEWDFVSTPPLIRLAYNLVKDPLEGRETYYTDGSCNRTSKEGKAGYVTDRGKDKVKVLEQ TTNQQAELEAFALALTDSEPQVNIIVDSQYVMGIIAAQPTETESPIVAKIIEEMIKKEAV YVGWVPAHKGLGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHGNVKELVHKFGIPQL VAKQIVNSCDKCQQKGEAIHGQVNADLGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIPQ ETGRQTALFLLKLASRWPITHLHTDNGANFTSPSVKMVAWWVGIEQTFGVPYNPQSQGVV EAMNHHLKNQIDRLRDQAVSIETVVLMATHCMNFKRRGGIGDMTPAERLVNMITTEQEIQ FFQAKNLKFQNFQVYYREGRDQLWKGPGELLWKGEGAVIIKVGTEIKVVPRRKAKIIRHY GGGKGLDCSADMEDTRQAREMAQSD >Q89928|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype B (isolate EHO)|Swiss-Prot MGARGSVLSGKKTDELEKVRLRPGGKKRYMLKHIVWAVNELERFGLAESRLGSKEGCRKI RKVLGPLVPTGSENLKSLYNTVCVIFCLHAEEKVKDTEEAKKIAQRHLAADTEKMPAMSK PSKPTSRLAYPVQQIAGNYSHLPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEGCTPYD INQMLNCVGEHQAAMQIIREIINEEAADWDQQHPSPGPMPAGQLREPRGSDIAGTTSTVE EQIQWMYRPQNPVPVGNIYRRWIQLGLQKCVRMYNPTNILDIKQGPKEPFQSYVDRFYKS LRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGIGGPGQKARLM AEALKEALTPSTNPFAAAQPRAGKRTVTCWNCGKAGHTARQCKAPRRQGCWKCGQQGHIM SKCPERQAGFLRVRPLGKEASQFPRPGTPGDSAICAPDEPSIRHDTSGCDSICTPCRSSR GDAKELHATREEAEGEQRETLQGGDRGFAAPQFSLWRRPVVKATIEGQSVEVLLDTGADD SIVAGIELGSNYTPKIVGGIGGFINTNEYKNVEIEVVGKRVRATVMTGDTPINIFGRNIL NSLGMTLNFPVARIEPVKVQLKPEKDGPKIRQWPLSKEKILALKEICEKMEKEGQLEEAP PTNPYNSPTFAIKKKDKNKWRMLIDFRELNKVTQEFTEVQLGIPHPAGLASKKRITVLDV GDAYFSVPLDPDFRQYTAFTLPAVNNAEPGKRYLYKVLPQGWKGSPAIFQYTMAKVLDPF RKANNDVTIIQYMDDILVASDRSDLEHDRVVSQLKELLNNMGFSTPEEKFQKDPPFKWMG YELWPKKWKLQKIQLPEKEVWTVNDIQKLVGVLNWAAQLFPGIKTRHICKLIRGKMTLTE EVQWTELAEAEFQENKIILEQEQEGSYYKEGVPLEATVQKNLANQWTYKIHQGDKILKVG KYAKVKNTHTNGVRLLAHVVQKIGKEALVIWGEIPMFHLPVERETWDQWWTDYWQVTWIP EWDFVSTPPLIRLAYNLVKDPLEGVETYYTDGSCNKASKEGKAGYVTDRGKDKVKPLEQT TNQQAELEAFALALQDSGPQVNIIVDSQYVMGIVAAQPTETESPIVREIIEEMIKKEKIY VGWVPAHKGLGGNQEVDHLVSQGIRQILFLEKIEPAQEEHEKYHNNVKELVHKFGIPQLV ARQIVNSCDKCQQKGEAIHGQVNSELGTWQMDCTHLEGKVIIVAVHVASGFIEAEVIPQE TGRQTALFLLKLASRWPITHLHTDNGANFTSQDVKMAAWWIGIEQTFGVPYNPESQGVVE AMNHHLKNQIDRIRDQAVSIETVVLMATHCMNFKRRGGIGDMTPAERIVNMITTEQEIQF LQTKNLKFQNFRVYYREGRDQLWKGPGDLLWKGEGAVIIKVGTEIKVIPRRKAKIIRNYG GGKELDCSADVEDTMQAREVAQSN >P18042|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate Ghana-1)|Swiss-Prot MGARNSVLRGKKADELEKIRLRPSGKKKYRLKHIVWAANELDKFGLAESLLESKEGCQKI LTVLDPLVPTGSENLKSLFNTVCVIWCLHAEEKVKDTEEAKKLVQRHLGAETGTAEKMPS TSRPTAPPSGRGRNFPVQQTGGGNYIHVPLSPRTLNAWVKLVEDKKFGAEVVPGFQALSE GCTPYDINQMLNCVGDHQAAMQIIREIINDEAADWDAQHPIPGPLPAGQLRDPRGSDIAG TTSTVEEQIQWMYRPQNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDVKQGPKEPFQSYV DRFYKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPG QKARLMAEALKEALTPPPIPFAAAQQRKVIRCWNCGKEGHSARQCRAPRRQGCWKCGKTG HVMAKCPERQAGFLRDGSMGKEAPQLPRGPSSSGADTNSTPSRSSSGSIGKIYAAGERAE GAEGETIQRGDGRLTAPRAGKSTSQRGDRGLAAPQFSLWKRPVVTAYIEVQPVEVLLDTG ADDSIVAGIQLGDNYVPKIVGGIGGFINTKEIKNIEIKVLNKRVRATIMTGDTPINIFGR NILTALGMSLNLPIAKIEPIKVTLKPGKDGPRLRQWPLTKEKIEALREICEKMEKEGQLE EAPPTNPYNTPTFAIKKKDKNKWRMLIDFRELNRVTQDFTEIQLGIPHPAGLAKKKRITV LDVGDAYFSIPLHEDFRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQHTMRQVL EPFRKANPDVILIQYMDDILIASDRTGLEHDKVVLQLKELLNGLGFSTPDEKFQKDPPLQ WMGYELWPTKWKLQKLQLPQKEIWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIKGKMT LTEEVQWTELAEAELEENKIILSQEQEGYYYQEEKELEATIQKNQDNQWTYKIHQEEKIL KVGKYAKIKNTHTNGVRLLAQVVQKIGKEALVIWGRIPKFHLPVERETWEQWWDNYWQVT WIPEWDFVSTPPLVRLTFNLVGDPIPGAETFYTDGSCNRQSKEGKARYVTDRGRDKVRVL ERTTNQQAELEAFAMTLTDSGPKVNIIVDSQYVMGIVVGQPTESESRIVNQIIEDMIKKE AVYVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLERIEPAQEEHEKYHSNMKELTHKFGIP QLVARQIVNTCAQCQQKGEAIHGQVNAEIGVWQMDCTHLEGKIIIVAVHVASGFIEAEVI PQESGRQTALFLLKLASRWPITHLHTDNGSNFTSQEVKMVAWWIGIEQSFGVPYNPQSQG VVEAMNHHLKNQISRIREQANTIETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQE IQFLQRKNSNFKNFQVYYREGRDQLWKGPGELLWKGDGAVIVKVGADIKVIPRRKAKIIR DYGGRQELDSSHLEGAREEDGEVA >Q74120|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate KR)|Swiss-Prot MGARSSVLRGKKVDELEKIRLRPGGKKKYRLKHIVWAANELGKFGLAESLLESKEGCQKI ITVLDPLVPTGSENLKSLFNTVCVIWCLHAEEKVKDTEGAKQIVQRHLVAETGTADKMPS TSRPAAPPSGRGGNYPVQQIAGNYSHVPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAADWDVQHPIPGPLPAGQLREPRGSDIAGT TSTVEEQIQWMFRAQNPIPVGNIYRRWIQIGLQKCVRMYNPTNILDVKQGPKEPFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLVQNANPDCKLVLKGLGMNPTLEEMLTACQGIGGPGQ KARLMAEALKEALAPAPIPFAAAQQRRTIKCWNCGKDGHSARQCRAPRRQGCWKCGKSGH VMANCPERQAGFLRDWPMGKEASQLPRDPSPAGADTNSTPSRPSSRPAREVLAAREEAER AENETIQGGDRGLTAPRTRRDTTQRGDRGFAAPQFSLWKRPVVTAYVEGQPVEVLLDTGA DDSIVAGIELGSNYSPKIVGGIGGFINTKEYKNVEIKVLNKKVKATIMTGDTPINIFGRN ILTALGMSLNLPVAKVDPIKVILKPGKDGPKVRQWPLTKEKIEALKEICEKMEREGQLEE APPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQEFTEIQLGIPHPAGLAKKRRITVL DIGDAYFSIPLHEDFRQYTAFTLPTVNNAEPGKRYIYKVLPQGWKGSPAIFQHTMRQVLE PFRKANPDVILVQYMDDILIASDRTDLEHDRTVLQLKELLNGLGFSTPDEKFQKDPPYKW MGYELWPTKWKLQKIQLPQKEVWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTL TEEVQWTELAEAELEENKIILSQEQEGCYYQEEKELEATVQKDQDNQWTYKIHQGEKILK VGKYAKIKNTHTNGVRLLAHVVQKIGKEALVIWGRIPKFHLPVERETWEQWWDNYWQVTW IPDWDFVSTPPLVRLAFNLVKDPIPGEETFYTDGSCNRQSKEGKAGYITDRGRDKVRILE QTTNQQAELEAFAMALTDSGPKANIIVDSQYVMGIVAGQPTESESKLVNQIIEEMIKKET LYVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNVKELSHKFGLPK LVARQIVNTCAQCQQKGEAIHGQVDAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIP QETGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWTGIEQSFGVPYNPQSQGV VEAMNHHLKNQISRIREQANTMETIVLMAVHCMNFKRRGGIGDMTPAERLINMITTEQEI QFLHAKNSKLKNFRVYFREGRDQLWKGPGELLWKGDGAVIVKVGTDIKIVPRRKAKIIRD YGGRREVDSSSHLEGTREDGEVA >P05962|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate NIH-Z)|Swiss-Prot MGARNSVLRGKKADELEKIRLRPGGKKKYKLKHIVWAANELDRFGLAESLLESKEGCQKI LTVLDPLVPTGSENLKSLFNTVCVIWCIHAEEKVKDTEGAKQIVQRHLVAETGTAEKMPN TSRPTAPPSGKNFPVQQVAGNYTHIPLSPGTLNAWVKLVEEKKFGAEVVPGFQALSEGCT PYDINQMLNCVGDHQAAMQIIREIINEEAADWDVAHPIPGPLPAGQLREPRGSDIAGTTS TVEEQIQWMFRPQNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDINQGPKEPFQSYVDRF YKSLRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTTCQGVGGPGQKA RLMAEALKEVMAPAPIPFAAAQQRKTFKCWNCGKEGHSARQWSAPRRQGCWKCGKSGHVM ANCPDRQAGFLRDWPLGKEGPQLPRGPSPAGANTNSTPIGSSSGPTGEIYAARKKAKGAE RETVQGSDRGLTAFRAGRDTMQGDDRGLAAPQFSLWKRPVVTAHIEGQPVEVLLDTRAND SIVAGIELGSNYSPKIVGGIGGFINTKEYKNVEIEVLGKRVKATIMTGDTPINIFGRNVL TALGMSLNLPVAKIEPIKIMLKPGKDGPRLKQWPLTKEKIEALKEICEKMEKEGQLEEAP PTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEIQLGIPHPAGLAKKRRITVLDV GDAYFSIPLHEDFRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRQILEPF RKANEDVIIIQYMDDILIASDRTDLEHDKVVLQLKELLNGLGFSTPDEKFQKDPPYRWMG YELWPTKWKLQKIQLPQKEVWTVNDIQKLVGVLNWAAQIYPGIKTKHLCRLIRGKMTLTE EVQWTELAEAELEENRIILSQKQEGHYYQEEKKLEATVQKDQDNQWTYKVHQGEKILKGG KICKDKKYPYQRVRLLAQVVQKIGKEALVIWGRIPKFHLPVERDTWEQWWDNYWQVTWIP DWDFVSTPPLVRLAFNLVGEPVPGAETFYTDGSCNRQSKEGKAGYITDRGRDRVKVLEQT TNQQAELEAFAMALTDSGPKANIIVDSQYVMGIVAGQPTESENRIVNQIIEEMIKKEAIY VAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNIKELSHKFGIPKLV ARQIVNTCAHVQQKGEAIHGQVNAELGTWQMDCTHLEGKVIIVAVHVASGFIEAEVIPQE SGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWVGIEQTFGVPYNPQSQGVVE AMNHHLKNQIDRIREQANTVETIVLMAVHCMNFKRRGGIGDMTPAERIINMITTEQEIQF LQAKNSKLKNFRVYFREGRDQLWKGPGELLWKGDGAVIVKVGTEIKVVPRRKAKIIKDYG GRQEMDSGSHLEGAREDGEMA >P04584|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate ROD)|Swiss-Prot MGARNSVLRGKKADELERIRLRPGGKKKYRLKHIVWAANKLDRFGLAESLLESKEGCQKI LTVLDPMVPTGSENLKSLFNTVCVIWCIHAEEKVKDTEGAKQIVRRHLVAETGTAEKMPS TSRPTAPSSEKGGNYPVQHVGGNYTHIPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAAEWDVQHPIPGPLPAGQLREPRGSDIAGT TSTVEEQIQWMFRPQNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDIKQGPKEPFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLVQNANPDCKLVLKGLGMNPTLEEMLTACQGVGGPGQ KARLMAEALKEVIGPAPIPFAAAQQRKAFKCWNCGKEGHSARQCRAPRRQGCWKCGKPGH IMTNCPDRQAGFLRTGPLGKEAPQLPRGPSSAGADTNSTPSGSSSGSTGEIYAAREKTER AERETIQGSDRGLTAPRAGGDTIQGATNRGLAAPQFSLWKRPVVTAYIEGQPVEVLLDTG ADDSIVAGIELGNNYSPKIVGGIGGFINTKEYKNVEIEVLNKKVRATIMTGDTPINIFGR NILTALGMSLNLPVAKVEPIKIMLKPGKDGPKLRQWPLTKEKIEALKEICEKMEKEGQLE EAPPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEIQLGIPHPAGLAKKRRITV LDVGDAYFSIPLHEDFRPYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQHTMRQVL EPFRKANKDVIIIQYMDDILIASDRTDLEHDRVVLQLKELLNGLGFSTPDEKFQKDPPYH WMGYELWPTKWKLQKIQLPQKEIWTVNDIQKLVGVLNWAAQLYPGIKTKHLCRLIRGKMT LTEEVQWTELAEAELEENRIILSQEQEGHYYQEEKELEATVQKDQENQWTYKIHQEEKIL KVGKYAKVKNTHTNGIRLLAQVVQKIGKEALVIWGRIPKFHLPVEREIWEQWWDNYWQVT WIPDWDFVSTPPLVRLAFNLVGDPIPGAETFYTDGSCNRQSKEGKAGYVTDRGKDKVKKL EQTTNQQAELEAFAMALTDSGPKVNIIVDSQYVMGISASQPTESESKIVNQIIEEMIKKE AIYVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNVKELSHKFGIP NLVARQIVNSCAQCQQKGEAIHGQVNAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVI PQESGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWIGIEQSFGVPYNPQSQG VVEAMNHHLKNQISRIREQANTIETIVLMAIHCMNFKRRGGIGDMTPSERLINMITTEQE IQFLQAKNSKLKDFRVYFREGRDQLWKGPGELLWKGEGAVLVKVGTDIKIIPRRKAKIIR DYGGRQEMDSGSHLEGAREDGEMA >P12451|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate SBLISY)|Swiss-Prot MGAKNSVLRGKKADELEKIRLRPGGKKKYRLKHIVWAANELDRFGLTESLLESKEGCQKI ISVLEPLVPTGSENLKSLYNTTCVIWCLHAEEKVKDTEEAKRIVGRHLVAETETAEKMPN ISRPTAPPSGKGGNFPVQQIGGNYVHLPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAADWDVQHPIPGPLPAGQLRDPRGSDIAGT TSTVEEQIEWMYRQENPVPVGNIYRRWIQIGLQKCVRMYNPTNILDIKQGPKESFQSYVD RFYKSLRAEQTDAAVKNWMTQTLLVQSNPDCKLVLKGLGMNPTLEEMLTACQGIGGPGQK ARLMAEALKEAMRPAPIPFAAAQQKRAIKCWNCGKEGHSARQCRAPRRQGCWKCGKSGHI MANCPDRQAGFLRAWTMGKEAPQLPRGPKFAGANTNSTPNGSSSGPTGEVHAAREKTERA ETKTIQRSDRGLAASRARRDTTQRDDRGLAAPQFSLWKRPVVTAYIEDQPVEVLLDTGAD DSIVAGIELGSNYSPKIVGGIGGFINTKEYKDVEIRVLNKKVRATIMTGDTPINIFGRNI LTALGMSLNLPVAKIEPVKVTLKPGKDGPKQRQWPLTREKIEALREICEKMEREGQLEEA PPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEVQLGIPHPAGLAKKRRITVLD VGDAYFSIPLYEDFRQYTAFTLPSVNNAEPGKRYIYKVLPQGWKGSPAIFQYTMRQVLEP FRKANPDVIIVQYMDDILIASDRTDLEHDKVVLQLKELLNGLGFSTPDEKFQKDPPYQWM GYELWPTKWKLQKIQLPQKEVWTVNDIQKLVGVLNWAAQIYPGIKTKHLCKLIRGKMTPT EEVQWTELAEAELEENKIILSQEQEGHYYQEEKELEATVQKDQDNQWTYKVHQGEKILKV GKYAKIKNTHTNGVRLLAQVVQKIGKEALVIWGRIPKFHLPVERETWEQWWDNYWQVTWI PDWDFVSTPPLVRLAFNLVKDPIPGAETFYTDGSCNRQSKEGKAGYITDRGKDKVRILEQ TTNQQAELEAFAMAVTDSGPKVNIVVDSQYVMGIVTGQPAESESRIVNKIIEEMIKKEAI YVAWVPAHKGIGGNQEIDHLVSQGIRQVLFLERIEPAQEEHGKYHSNVKELAHKFGLPNL VARQIVNTCAQCQQKGEAIHGQVNAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIPQ ESGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWVGIEQSFGVPYNPQSQGVV EAMNHHLKNQIERIREQANTMETIVLMAVHCMNFKRRGGIGDMTPVERLVNMITTEQEIQ FLQAKNSKLKNFRVYFREGRNQLWQGPGELLWKGDGAVIVKVGTDIKVIPRRKAKIIRDY GPRQEMDSGSHLEGAREDGEMA >P20876|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype A (isolate ST)|Swiss-Prot MGARNSVLRGKKADELEKIRLRPGGKKKYRLKHIVWAANELDRFGLAESLLESKEGCQKI LTVLDPLVPTGSENLKSLFNTVCVIWCIHAEEKAKDTEEAKQKVQRHLVAETKTTEKMPS TSRPTAPPSGNGGNFPVQQVAGNYTHVPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEG CTPYDINQMLNCVGDHQAAMQIIREIINEEAADWDAQHPIPGPLPAGQLREPRGSDIAGT TSTVEEQIQWMFRPQNPVPVGSIYRRWIQIGLQKCVRMYNPTNILDIKQGPKEPFQSYVD RFYKSLRAEQTDPAVKNWMTQTLLVQNANPDCKLVLKGLGINPTLEEMLTACQGVGGPGQ KARLMAEALKEAMAPAPIPFAAAQQRRTIKCWNCGKEGHSARQCRAPRRQGCWKCGKAGH IMAKCPERQAGFLRVGPMGKEAPQFPCGPNPAGADTNSTPDRPSRGPTREVHAAREKAER AEREAIQRSDRGLPAARETRDTMQRDDRGLAAPQFSLWKRPVVTAHVEGQPVEVLLDTGA DDSIVAGVELGSNYSPKIVGGIGGFINTKEYKNVEIRVLNKRVRATIMTGDTPINIFGRN ILTALGMSLNLPVAKIEPIKIMLKPGKDGPKLRQWPLTKEKIEALKEICEKMEREGQLEE APPTNPYNTPTFAIKKKDKNKWRMLIDFRELNKVTQDFTEIQLGIPHPAGLAKKKRITVL DVGDAYFSIPLHEDFRQYTAFTLPSINNAEPGKRYIYKVSPQGWKGSPAIFQYTMRQVLE PFRKANPDIILIQYMDDILIASDRTDLEHDRVVLQLKELLNGLGFSTPDEKFQKDPPYQW MGYELWPTKWKLQRIQLPQKEVWTVNDIQKLVGVLNWAAQIYPGIKTRNLCRLIRGKMTL TEEVQWTELAEAELEENKIILSQEQEGCYYQEEKELEATVQKDQDNQWTYKIHQGGKILK VGKYAKVKNTHTNGVRLLAQVVQKIGKEALVIWGRIPKFHLPVERDTWEQWWDNYWQVTW IPDWDFISTPPLVRLVFNLVKDPILGAETFYTDGSCNKQSREGKAGYITDRGRDKVRLLE QTTNQQAELEAFAMAVTDSGPKANIIVDSQYVMGIVAGQPTESESKIVNQIIEEMIKKEA IYVAWVPAHKGIGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHSNVKELSHKFGLPK LVARQIVNTCTQCQQKGEAIHGQVNAELGTWQMDCTHLEGKIIIVAVHVASGFIEAEVIP QESGRQTALFLLKLASRWPITHLHTDNGANFTSQEVKMVAWWIGIEQSFGVPYNPQSQGV VEAMNHHLKNQISRIREQANTVETIVLMAVHCMNFKRRGGIGDMTPAERLINMVTAEQEI QFLQAKNSKLQNFRVYFREGRDQLWKGPGELLWKGDGAVIVKVGADIKIIPRRKAKIIKD YGGRQEMDSGSNLEGAREDGEVA >Q76634|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 2 subtype B (isolate UC1)|Swiss-Prot MGARSSVLSGKKTDELEKVRLRPGGKKRYCLKHIIWAVNELDRFGLAESLLESKEGCHKI LTVLAPLVPTGSENLKSLFNTVCVIYCLHAEEKVKDTEEAKKIAQRHLAADTEKMPATSR PTAPPSGGNYPVQQIAGNYVHMPLSPRTLNAWVKLVEEKKFGAEVVPGFQALSEGCTPYD INQMLNCVGDHQAAMQIIREIINEEAADWDQQHPIPGPLPAGQLRDPRGSDIAGTTSTVE EQIQWMYRAQNPVPVGNIYRRWIQIGLQKCVRMYNPTNILDIKQGPKEPFQSYVDRFYKS LRAEQTDPAVKNWMTQTLLIQNANPDCKLVLKGLGMNPTLEEMLTACQGIGGPGQKARLM AEALKEALTPAPIPFAAAQQKAGKRGTVTCWNCGKVGHTAKQCRAPRRQGCWKCGKQGHI MSKCPERQAGFLRVRTLGKEASQLPHDPSASGSDTICTPDGPSRGHDTSGGDTICAPCRS SSGDAEKLHEDGETAEREPRETLQGGDRGFAAPQFSLWRRPVVRACIEGQPVEVLLDTGA DDSIVAGIELGSNYTPKIVGGIGGFINTKEYKDVEIEVVGKRVRATIMTGDTPINIFGRN ILNTLGMTLNFPVAKIEPVKVKLKPGKDGPKIRQWPLSKEKILALKEICEKMEKEGQLEE APPTNPYNTPTFAIKKRDKNKWRMLIDFRELNKVTQDFTEVQLGIPHPAGLAEKRRITVL DVGDAYFSIPLDPNFRQYTAFTLPSINNAEPGKRYIYKVLPQGWKGSPAIFQYSMRKVLD PFRKANSDVIIIQYMDDILIASDRSDLEHDRVVSQLKELLNDMGFSTPEEKFQKDPPFKW MGYELWPKRWKLQKIQLPEKEVWTVNDIQKLVGVLNWAAQLFPGIKTRHICKLIRGKMTL TEEVQWTELAEAELQENKIILEQEQEGSYYKEGVPLEATVQKNLANQWTYKIHQGNRILK VGKYAKVKNTHTNGVRLLAHVVQKIGKEALVIWGEIPVFHLPVERETWDQWWTDYWQVTW IPEWDFVSTPPLVRLAYNLVKDPLEKVETYYTDGSCNRASKEGKAGYVTDRGKDKVKVLE QTTNQQAELEAFALALQDSGPQVNIIVDSQYVMGIVAGQPTETESPLVNQIIEEMIKKEA IYVGWVPAHRGLGGNQEVDHLVSQGIRQVLFLEKIEPAQEEHEKYHGNVKELVHKFGLPQ LVAKQIVNSCDKCQQKGEAVHGQVNAELGTWQMDCTHLEGKVIIVAVHVASGFIEAEVIP QETGRQTALFLLKLASRWPITHLHTDNGANFTSQDVKMAAWWIGIEQTFGVPYNPQSQGV VEAMNHHLKNQIDRIRDQAVSIETVVLMAAHCMNFKRRGGIGDMTPAERLVNMITTEQEI QFFQAKNLKFQNFQVYYREGRDQLWKGPGELLWKGEGAVLIKVGTEIKVIPRRKAKIIRH YGGGKELDCGTDMEDTRQAREMAQSGQVPEA >P33459|retroviral ribonuclease H|EC 3.1.26.13|Caprine arthritis encephalitis virus (strain Cork)|Swiss-Prot TRNHMSQLWKERTYAKRMQRKERHKGKTAGKREEGDTCGAVRSSYGITSAPPMVQVRIGS QQRNLLFDTGADRTIVRWHEGSGNPAGRIKLQGIGGIVEGEKWNNVELEYKGETRKGTIV VLPQSPVEVLGRDNMARFGIKIIMANLEEKRIPITKVKLKEGCTGPHVPQWPLTEEKLKG LTEIIDKLVEEGKLGKAPPHWTCNTPIFCIKKKSGKWRMLIDFRELNKQTEDLTEAQLGL PHPGGLQKKKHVTILDIGDAYFTIPLYEPYREYTCFTLLSPNNLGPCKRYYWKVLPQGWK LSPSVYQFTMQEILEDWIQQHPEIQFGIYMDDIYIGSDLEIKKHREIVKDLANYIAQYGF TLPEEKRQKGYPAKWLGFELHPQTWKFQKHTLPELTKGTITLNKLQKLVGELVWRQSIIG KSIPNILKLMEGDRELQSERKIEEVHVKEWEACRKKLEEMEGNYYNKDKDVYGQLAWGDK AIEYIVYQEKGKPLWVNVVHNIKNLSIPQQVIKAAQKLTQEVIIRTGKIPWILLPGKEED WRLELQLGNITWMPKFWSCYRGHTRWRKRNIIEEVVEGPTYYTDGGKKNKVGSLGFIVST GEKFRKHEEGTNQQLELRAIEEALKQGPQTMNLVTDSRYAFEFLLRNWDEEVIKNPIQAR IMEIAHKKDRIGVHWVPGHKGIPQNEEIDKYISEIFLAKEGEGILPKREEDAGYDLICPE EVTIEPGQVKCIPIELRLNLKKSQWAMIATKSSMAAKGVFTQGGIIDSGYQGQIQVIMYN SNKIAVVIPQGRKFAQLILMDKKHGKLEPWGESRKTERGEKGFGSTGMYWIENIPLAEED HTKWHQDARSLHLEFEIPRTAAEDIVNQCEICKEARTPAVIRGGNKRGVNHWQVDYTHYE NIILLVWVETNSGLIYAEKVKGESGQEFRIKVMHWYALFGPESLQSDNGPAFAAEPTQLL MQYLGVKHTTGIPWNPQSQAIVERAHQLLKSTLKKFQPQFVAVESAIAAALVAINIKRKG GLGTSPMDIFIYNKEQKRINNKYNKNSQKIQFCYYRIRKRGHQESGKDQPRYCGKGKEPI VVKDIESEKYLVIPYKDAKFIPPPTKEKE >P11204|retroviral ribonuclease H|EC 3.1.26.13|Equine infectious anemia virus (isolate 1369)|Swiss-Prot TAWTFLKAMQKCSKKREARGSREAPETNFPDTTEESAQQICCTRDSSDSKSVPRSERNKK GIQCQGEGSSRGSQPGQFVGVTYNLEKRPTTIVLINDTPLNVLLDTGADTSVLTTAHYNR LKYRGRKYQGTGIIGVGGNVETFSTPVTIKKKGRHIKTRMLVADIPVTILGRDILQDLGA KLVLAQLSKEIKFRKIELKEGTMGPKIPQWPLTKEKLEGAKEIVQRLLSEGKISEASDNN PYNSPIFVIKKRSGKWRLLQDLRELNKTVQVGTEISRGLPHPGGLIKCKHMTVLDIGDAY FTIPLDPEFRPYTAFTIPSINHQEPDKRYVWNCLPQGFVLSPYIYQKTLQEILQPFRERY PEVQLYQYMDDLFVGSNGSKKQHKELIIELRAILLEEGFETPDDKLQEVPPYSWLGYQLC PENWKVQKMQLDMVKNPTLNDVQKLMGNITWMSSGVPGLTVKHIAATTKGCLELNQKVIW TEEAQKELEENNEKIKNAQGLQYYNPEEEMLCEVEITKNYEATYVIKQSQGILWAGKKIM KANKGWSTVKNLMLLLQHVATESITRVGKCPTFKVPFTKEQVMWEMQKGWYYSWLPEIVY THQVVHDDWRMKLVEEPTSGITIYTDGGKQNGEGIAAYVTSNGRTKQKRLGPVTHQVAER MAIQMALEDTRDKQVNIVTDSYYCWKNITEGLGLEGPQSPWWPIIQNIREKEIVYFAWVP GHKGICGNQLADEAAKIKEEIMLAYQGTQIKEKRDEDAGFDLCVPYDIMIPVSDTKIIPT DVKIQVPPNSFGWVTGKSSMAKQGLLINGGIIDEGYTGEIQVICTNIGKSNIKLIEGQKF AQLIILQHHSNSRQPWDENKISQRGDKGFGSTGVFWVENIQEAQDEHENWHTSPKILARN YKIPLTVAKQITQECPHCTKQGSGPAGCVMRSPNHWQADCTHLDNKIILTFVESNSGYIH ATLLSKENALCTSLAILEWARLFSPKSLHTDNGTNFVAEPVVNLLKFLKIAHTTGIPYHP ESQGIVERANRTLKEKIQSHRDNTQTLEAALQLALITCNKGRESMGGQTPWEVFITNQAQ VIHEKLLLQQAQSSKKFCFYKIPGEHDWKGPTRVLWKGDGAVVVNDEGKGIIAVPLTRTK LLIKPN >P32542|retroviral ribonuclease H|EC 3.1.26.13|Equine infectious anemia virus (isolate CL22)|Swiss-Prot TAWTFLKAMQKCSKKREARGSREAPETNFPDTTEESAQQICCTRDSSDSKSVPRSERNKK GIQCQGEGSSRGSQPGQFVGVTYNLEKRPTTIVLINDTPLNVLLDTGADTSVLTTAHYNR LKYRGRKYQGTGIIGVGGNVETFSTPVTIKKKGRHIKTRMLVADIPVTILGRDILQDLGA KLVLAQLSKEIKFRKIELKEGTMGPKIPQWPLTKEKLEGAKEIVQRLLSEGKISEASDNN PYNSPIFVIKKRSGKWRLLQDLRELNKTVQVGTEISRGLPHPGGLIKCKHMTVLDIGDAY FTIPLDPEFRPYTAFTIPSINHQEPDKRYVWNCLPQGFVLSPYIYQKTLQEILQPFRERY PEVQLYQYMDDLFVGSNGSKKQHKELIIELRAILLEKGFETPDDKLQEVPPYSWLGYQLC PENWKVQKMQLDMVKNPTLNDVQKLMGNITWMSSGVPGLTVKHIAATTKGCLELNQKVIW TEEAQKELEENNEKIKNAQGLQYYNPEEEMLCEVEITKNYEATYVIKQSQGILWAGKKIM KANKGWSTVKNLMLLLQHVATESITRVGKCPTFKVPFTKEQVMWEMQKGWYYSWLPEIVY THQVVHDDWRMKLVEEPTSGITIYTDGGKQNGEGIAAYVTSNGRTKQKRLGPVTHQVAER MAIQMALEDTRDKQVNIVTDSYYCWKNITEGLGLEGPQSPWWPIIQNIREKEIVYFAWVP GHKGICGNQLADEAAKIKEEIMLAYQGTQIKEKRDEDAGFDLCVPYDIMIPVSDTKIIPT DVKIQVPPNSFGWVTGKSSMAKQGLLINGGIIDEGYTGEIQVICTNIGKSNIKLIEGQKF AQLIILQHHSNSRQPWDENKISQRGDKGFGSTGVFWVENIQEAQDEHENWHTSPKILARN YKIPLTVAKQITQECPHCTKQGSGPAGCVMRSPNHWQADCTHLDNKIILTFVESNSGYIH ATLLSKENALCTSLAILEWARLFSPKSLHTDNGTNFVAEPVVNLLKFLKIAHTTGIPYHP ESQGIVERANRTLKEKIQSHRDNTQTLEAALQLALITCNKGRESMGGQTPWEVFITNQAQ VIHEKLLLQQAQSSKKFCFYKIPGEHDWKGPTRVLWKGDGAVVVNDEGKGIIAVPLTRTK LLIKPN >P03371|retroviral ribonuclease H|EC 3.1.26.13|Equine infectious anemia virus (strain Wyoming)|Swiss-Prot TAWTFLKAMQKCSKKREARGSREAPETNFPDTTEESAQQICCTRDSSDSKSVPRSERNKK GIQCQGEGSSRGSQPGQFVGVTYNLEKRPTTIVLINDTPLNVLLDTGADTSVLTTAHYNR LKYRGRKYQGTGIIGVGGNVETFSTPVTIKKKGRHIKTRMLVADIPVTILGRDILQDLGA KLVLAQLSKEIKFRKIELKEGTMGPKIPQWPLTKEKLEGAKETVQRLLSEGKISEASDNN PYNSPIFVIKKRSGKWRLLQDLRELNKTVQVGTEISRGLPHPGGLIKCKHMTVLDIGDAY FTIPLDPEFRPYTAFTIPSINHQEPDKRYVWKCLPQGFVLSPYIYQKTLQEILQPFRERY PEVQLYQYMDDLFVGSNGSKKQHKELIIELRAILQKGFETPDDKLQEVPPYSWLGYQLCP ENWKVQKMQLDMVKNPTLNDVQKLMGNITWMSSGVPGLTVKHIAATTKGCLELNQKVIWT EEAQKELEENNEKIKNAQGLQYYNPEEEMLCEVEITKNYEATYVIKQSQGILWAGKKIMK ANKGWSTVKNLMLLLQHVATESITRVGKCPTFKVPFTKEQVMWEMQKGWYYSWLPEIVYT HQVVHDDWRMKLVEEPTSGITIYTDGGKQNGEGIAAYVTSNGRTKQKRLGPVTHQVAERM AIQMALEDTRDKQVNIVTDSYYCWKNITEGLGLEGPQNPWWPIIQNIREKEIVYFAWVPG HKGIYGNQLADEAAKIKEEIMLAYQGTQIKEKRDEDAGFDLCVPYDIMIPVSDTKIIPTD VKIQVPPNSFGWVTGKSSMAKQGLLINGGIIDEGYTGEIQVICTNIGKSNIKLIEGQKFA QLIILQHHSNSRQPWDENKISQRGDKGFGSTGVFWVENIQEAQDEHENWHTSPKILARNY KIPLTVAKQITQECPHCTKQGSGPAGCVMRSPNHWQADCTHLDNKIILHFVESNSGYIHA TLLSKENALCTSLAILEWARLFSPKSLHTDNGTNFVAEPVVNLLKFLKIAHTTGIPYHPE SQGIVERANRTLKEKIQSHRDNTQTLEAALQLALITCNKGRESMGGQTPWEVFITNQAQV IHEKLLLQQAQSSKKFCFYKIPGEHDWKGPTRVLWKGDGAVVVNDEGKGIIAVPLTRTKL LIKPN >P16088|retroviral ribonuclease H|EC 3.1.26.13|Feline immunodeficiency virus (isolate Petaluma)|Swiss-Prot KEFGKLEGGASCSPSESNAASSNAICTSNGGETIGFVNYNKVGTTTTLEKRPEILIFVNG YPIKFLLDTGADITILNRRDFQVKNSIENGRQNMIGVGGGKRGTNYINVHLEIRDENYKT QCIFGNVCVLEDNSLIQPLLGRDNMIKFNIRLVMAQISDKIPVVKVKMKDPNKGPQIKQW PLTNEKIEALTEIVERLEKEGKVKRADSNNPWNTPVFAIKKKSGKWRMLIDFRELNKLTE KGAEVQLGLPHPAGLQIKKQVTVLDIGDAYFTIPLDPDYAPYTAFTLPRKNNAGPGRRFV WCSLPQGWILSPLIYQSTLDNIIQPFIRQNPQLDIYQYMDDIYIGSNLSKKEHKEKVEEL RKLLLWWGFETPEDKLQEEPPYTWMGYELHPLTWTIQQKQLDIPEQPTLNELQKLAGKIN WASQAIPDLSIKALTNMMRGNQNLNSTRQWTKEARLEVQKAKKAIEEQVQLGYYDPSKEL YAKLSLVGPHQISYQVYQKDPEKILWYGKMSRQKKKAENTCDIALRACYKIREESIIRIG KEPRYEIPTSREAWESNLINSPYLKAPPPEVEYIHAALNIKRALSMIKDAPIPGAETWYI DGGRKLGKAAKAAYWTDTGKWRVMDLEGSNQKAEIQALLLALKAGSEEMNIITDSQYVIN IILQQPDMMEGIWQEVLEELEKKTAIFIDWVPGHKGIPGNEEVDKLCQTMMIIEGDGILD KRSEDAGYDLLAAKEIHLLPGEVKVIPTGVKLMLPKGYWGLIIGKSSIGSKGLDVLGGVI DEGYRGEIGVIMINVSRKSITLMERQKIAQLIILPCKHEVLEQGKVVMDSERGDNGYGST GVFSSWVDRIEEAEINHEKFHSDPQYLRTEFNLPKMVAEEIRRKCPVCRIIGEQVGGQLK IGPGIWQMDCTHFDGKIILVGIHVESGYIWAQIISQETADCTVKAVLQLLSAHNVTELQT DNGPNFKNQKMEGVLNYMGVKHKFGIPGNPQSQALVENVNHTLKVWIQKFLPETTSLDNA LSLAVHSLNFKRRGRIGGMAPYELLAQQESLRIQDYFSAIPQKLQAQWIYYKDQKDKKWK GPMRVEYWGQGSVLLKDEEKGYFLIPRRHIRRVPEPCALPEGDE >P19028|retroviral ribonuclease H|EC 3.1.26.13|Feline immunodeficiency virus (strain San Diego)|Swiss-Prot KKFGKLEGGASCSPSESSAANSNAICTSNGGKIIGFINYNKVGTTTSLEKRPEILIFVNG YPIKFLLDTGADITILNRRDFQVKNSIENGRQNMIGVGGGKRGTNYINVHLEIRDENYKT QCIFGNVCVLEDNSLIQPLLGRDNMIKFNIRLVMAQISDKIPIVKVKMKDPNKGPQIKQW PLSNEKIEALTEIVERLEREGKVKRADPNNPWNTPVFAIKKKSGKWRMLIDFRELNKLTE KGAEVQLGLPHPAGLQMKKQITVLDIGDAYFTNPLDPDYAPYTAFTLPRKNNAGPGRRFV WCSLPQGWILSPLIYQSTLDNIIQPFIRQNPQLDIYQYMDDIYIGSNLSKKEHKEKVEEL RKLLLWWGFETPEDKLQEEPPYKWMGYELHPLTWTIQQKQLEIPEKPTLNELQKLAGKIN WASQTIPELSIKSLTNMTRGNQNLNSTREWTEEARLEVQKAKRAIEEQVQLGYYDPSKEL YAKLSLVGPHQISYQVYQKCPEKILWYGKMSRQKKKAENTCDIALRACYKIREESIIRIG KEPRYEIPTSREAWESNLINSPYLKAPPPEVDYIHAALNIKRALSMIKDPPISGAETWYI DGGRKLGKAAKAAYWTDTGKWQVMELEGSNQKAEIQALLLALKAGPEEMNIITDSQYMIN ILSQQPDKMEGIWQEVLEELEKKTAIFIDWVPGHKGIPGNEEVDKLCQTMMIIEGDGILD KRTEDAGYDLLAAKEIHLLPGEVKVIPTGVKLMLPKGHWGLIMGKSSIGSKGLDVLGGVI DEGYRGEIGVIMINLSKKSITLLEQQKIAQLIILPHKHEALEQGKVVMDSERGEKGYGST GVFSSWVDRIEEAETNHEKFHSDPQYLRTEFNLPKMVAEEIRRKCPVCRIRGEQVGGQLK IGPGIWQMDCTHFDGKIILVAIHVESGYIWAQIISQETADCTVKAVLQLLSAHIVTELQT DNGPNFKNQKMEGVLNYMGVKHKFGIPGNPQSQALVENVNQTLKVWVHKFLPETTSLDNA LALAVHCLNFKQRGRIGGMAPYELLAQQESLRIQDYFSAIPQKLQAQWIYYKDQKDKKWK GPMRVEYWGQGSVLLKDEEKGYFLIPRRHVKRVPEPCALPEGDE >P31822|retroviral ribonuclease H|EC 3.1.26.13|Feline immunodeficiency virus (isolate TM2)|Swiss-Prot ENLGKREGGASCSPSKPSAANSTICTSNGGETIRFINYNTIGTTTTLERRPEIQIFVNGH PIKFLLDTGADITILNRKDFQIGNSIENGKQNMIGVGGGKRGTNYINVHLEIRDENYRMQ CIFGNVCVLEDNSLIQPLLGRDNMIKFNIRLVMAQISEKIPIVKVRMKDPTQGPQVKQWP LSNEKIEALTDIVERLESEGKVKRADPNNPWNTPVFAIKKKSGKWRMLIDFRVLNKLTDK GAEVQLGLPHPAGLQMKKQVTVLDIGDAYFTIPLDPDYAPYTAFTLPRKNNAGPGRRYVW CSLPQGWVLSPLIYQSTLNNILQPFIKQNSELDIYQYMDDIYIGSNLNKKEHKQKVEELR KLLLWWGFETPEDKLQEEPPYKWMGYELHPLTWSIQQKQLEIPERPTLNELQKLAGKINW ASQTIPDLSIKELTNMMRGDQKLDSIREWTVEAKREVQKAKEAIETQAQLNYYDPNRGLY AKLSLVGPHQICYQVYQKNPEHILWYGKINRQKKKAENTCDIALRACYKIREESIIRIGK EPVYEIPASREAWESNLIRSPYLKAPPPEVEFIHAALSIKRALSMIQDAPIIGAETWYID GSRKQGKAARAAYWTNTGKWQIMEIEGSNQKAEVQALLLALKAGSEEMNIITDSQYILNI LNQQPDLMEGLWQEVLEQMEKKIAIFIDWVPGHKGIPGNEEVDKLCQTMMIIEGEGILEK RSEDAGYDLLAAAQETHFLPGEVRIVPTKTRIMLPKGHWGLIMGKSSIGSKGVDVLGGVI DEGYRGELGVIMINLTKKSITILEKQKIAQLIILPCRHEGLQQGEIQMNSERGEKGFGSA GVFSSWVDRIEEAELNHEKFHSDPQYLRTEFNLPRIVAEEIKRKCPLCRIRGEQVGGQLK IRPGIWQMDCTHFNGKIIIVAVHVESGFLWAQIIPQETADCTVKALLQLICAHNVTELQT DNGPNFKNQKMEGLLNYMGIKHKLGIPGNPQSQALVENANNTLKVWIQKFLPETTSLDNA LALALHCLNFKQRGRLGRMAPYELYIQQESLRIQDYFSAIPQKLMMQWLYYKDQKDKKWK GPMRVEYWGQGSVLLKDEEKGIFLVPRRHIRRVPEPCTLPEGDE >L7JYM3|retroviral ribonuclease H|EC 3.1.26.13|Trachipleistophora hominis|TrEMBL SQGVKSSPNKPEFDNNRLNWWYRTIQQYDFTIEYGKPINLVKADALSRKHEKVKEPTEVN KKTVKRHETINEKHLFAVDGKKYCRFDSGIVRGVPESENTEKLIIEAHLKTNHRGLVPIY YELKERYYWLGMKRHITEIIKGVRRVSGMRGTHRR >P0A7Y4|retroviral ribonuclease H|EC 3.1.26.13|Escherichia coli (strain K12)|Swiss-Prot MLKQVEIFTDGSCLGNPGPGGYGAILRYRGREKTFSAGYTRTTNNRMELMAAIVALEALK EHCEVILSTDSQYVRQGITQWIHNWKKRGWKTADKKPVKNVDLWQRLDAALGQHQIKWEW VKGHAGHPENERCDELARAAAMNPTLEDTGYQVEV >A0A059PIR4|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus 1|TrEMBL VGKLNWASQIYAGIKVKQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGAYYD PSKDLIAEIQKQGEGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKIATESI VIWGKIPKFRLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETF YVDGAANRETKLGKAGYVTNRGRQKVVTLTDTTNQKTELQAIYLALQDSGLEVNIVTDSQ YALGIIQAQPDQSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL >P14350|retroviral ribonuclease H|EC 3.1.26.13|Human spumaretrovirus|Swiss-Prot MNPLQLLQPLPAEIKGTKLLAHWDSGATITCIPESFLEDEQPIKKTLIKTIHGEKQQNVY YVTFKVKGRKVEAEVIASPYEYILLSPTDVPWLTQQPLQLTILVPLQEYQEKILSKTALP EDQKQQLKTLFVKYDNLWQHWENQVGHRKIRPHNIATGDYPPRPQKQYPINPKAKPSIQI VIDDLLKQGVLTPQNSTMNTPVYPVPKPDGRWRMVLDYREVNKTIPLTAAQNQHSAGILA TIVRQKYKTTLDLANGFWAHPITPESYWLTAFTWQGKQYCWTRLPQGFLNSPALFTADVV DLLKEIPNVQVYVDDIYLSHDDPKEHVQQLEKVFQILLQAGYVVSLKKSEIGQKTVEFLG FNITKEGRGLTDTFKTKLLNITPPKDLKQLQSILGLLNFARNFIPNFAELVQPLYNLIAS AKGKYIEWSEENTKQLNMVIEALNTASNLEERLPEQRLVIKVNTSPSAGYVRYYNETGKK PIMYLNYVFSKAELKFSMLEKLLTTMHKALIKAMDLAMGQEILVYSPIVSMTKIQKTPLP ERKALPIRWITWMTYLEDPRIQFHYDKTLPELKHIPDVYTSSQSPVKHPSQYEGVFYTDG SAIKSPDPTKSNNAGMGIVHATYKPEYQVLNQWSIPLGNHTAQMAEIAAVEFACKKALKI PGPVLVITDSFYVAESANKELPYWKSNGFVNNKKKPLKHISKWKSIAECLSMKPDITIQH EKGISLQIPVFILKGNALADKLATQGSYVVNCNTKKPNLDAELDQLLQGHYIKGYPKQYT YFLEDGKVKVSRPEGVKIIPPQSDRQKIVLQAHNLAHTGREATLLKIANLYWWPNMRKDV VKQLGRCQQCLITNASNKASGPILRPDRPQKPFDKFFIDYIGPLPPSQGYLYVLVVVDGM TGFTWLYPTKAPSTSATVKSLNVLTSIAIPKVIHSDQGAAFTSSTFAEWAKERGIHLEFS TPYHPQSGSKVERKNSDIKRLLTKLLVGRPTKWYDLLPVVQLALNNTYSPVLKYTPHQLL FGIDSNTPFANQDTLDLTREEELSLLQEIRTSLYHPSTPPASSRSWSPVVGQLVQERVAR PASLRPRWHKPSTVLKVLNPRTVVILDHLGNNRTVSIDNLKPTSHQNGTTNDTATMDHLE KNE >P35956|retroviral ribonuclease H|EC 3.1.26.13|Maedi visna virus (strain KV1772)|Swiss-Prot MAKQGSKEKKGYPELKEVIKATCKIRVGPGKETLTEGNCLWALKTIDFIFEDLKTEPWTI TKMYTVWDRLKGLTPEETSKREFASLQATLACIMCSQMGMKPETVQAAKGIISMKEGLHE NKEAKGEKVEQLYPNLEKHREVYPIVNLQAGGRSWKAVESVVFQQLQTVAMQHGLVSEDF ERQLAYYATTWTSKDILEVLAMMPGNRAQKELIQGKLNEEAERWVRQNPPGPNVLTVDQI MGVGQTNQQASQANMDQARQICLQWVITALRSVRHMSHRPGNPMLVKQKNTESYEDFIAR LLEAIDAEPVTDPIKTYLKVTLSYTNASTDCQKQMDRTLGTRVQQATVEEKMQACRDVGS EGFKMQLLAQALRPQGKAGQKGVNQKCYNCGKPGHLARQCRQGIICHHCGKRGHMQKDCR QKKQQGKQQEGATCGAVRAPYVVTEAPPKIEIKVGTRWKKLLVDTGADKTIVTSHDMSGI PKGRIILQGIGGIIEGEKWEQVHLQYKDKIIRGTIVVLATSPVEVLGRDNMRELGIGLIM ANLEEKKIPSTRVRLKEGCKGPHIAQWPLTQEKLEGLKEIVDRLEKEGKVGRAPPHWTCN TPIFCIKKKSGKWRMLIDFRELNKQTEDLAEAQLGLPHPGGLQRKKHVTILDIGDAYFTI PLYEPYRQYTCFTMLSPNNLGPCVRYYWKVLPQGWKLSPAVYQFTMQKILRGWIEEHPMI QFGIYMDDIYIGSDLGLEEHRGIVNELASYIAQYGFMLPEDKRQEGYPAKWLGFELHPEK WKFQKHTLPEITEGPITLNKLQKLVGDLVWRQSLIGKSIPNILKLMEGDRALQSERYIES IHVREWEACRQKLKEMEGNYYDEEKDIYGQLDWGNKAIEYIVFQEKGKPLWVNVVHSIKN LSQAQQIIKAAQKLTQEVIIRTGKIPWILLPGREEDWILELQMGNINWMPSFWSCYKGSV RWKKRNVIAEVVPGPTYYTDGGKKNGRGSLGYITSTGEKFRIHEEGTNQQLELRAIEEAC KQGPEKMNIVTDSRYAYEFMLRNWDEEVIRNPIQARIMELVHNKEKIGVHWVPGHKGIPQ NEEIDRYISEIFLAKEGRGILQKRAEDAGYDLICPQEISIPAGQVKRIAIDLKINLKKDQ WAMIGTKSSFANKGVFVQGGIIDSGYQGTIQVVIYNSNNKEVVIPQGRKFAQLILMPLIH EELEPWGETRKTERGEQGFGSTGMYWIENIPLAEEEHNKWHQDAVSLHLEFGIPRTAAED IVQQCDVCQENKMPSTLRGSNKRGIDHWQVDYTHYEDKIILVWVETNSGLIYAERVKGET GQEFRVQTMKWYAMFAPKSLQSDNGPAFVAESTQLLMKYLGIEHTTGIPWNPQSQALVER THQTLKNTLEKLIPMFNAFESALAGTLITLNIKRKGGLGTSPMDIFIFNKEQQRIQQQSK SKQEKIRFCYYRTRKRGHPGEWQGPTQVLWGGDGAIVVKDRGTDRYLVIANKDVKFIPPP KEIQKE >P04591|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)|Swiss-Prot MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQI LGQLQPSLQTGSEELRSLYNTVATLYCVHQRIEIKDTKEALDKIEEEQNKSKKKAQQAAA DTGHSNQVSQNYPIVQNIQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGAT PQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRVHPVHAGPIAPGQMREPRGSDIAGTT STLQEQIGWMTNNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRF YKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPAATLEEMMTACQGVGGPGHKA RVLAEAMSQVTNSATIMMQRGNFRNQRKIVKCFNCGKEGHTARNCRAPRKKGCWKCGKEG HQMKDCTERQANFLGKIWPSYKGRPGNFLQSRPEPTAPPEESFRSGVETTTPPQKQEPID KELYPLTSLRSLFGNDPSSQ >A0A076Q3N8|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus 1|TrEMBL FFREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGRDNNSPSEAGADR QGTVSFNFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGG FIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLK PGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIP SINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDL EIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWT VNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQ KITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEP IVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTTNQKTELQAIYLALQDSGLEV NIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS AGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQ VDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTI HTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLK TAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED >D3XFN5|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus 1|TrEMBL PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYD QILIEICGNKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLKPGMDGPKV KQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELN KRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPG IRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTK IEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLV GKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDP SKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIV IWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFY VDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQY ALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL >A7YKL0|retroviral ribonuclease H|EC 3.1.26.13|Human immunodeficiency virus 1|TrEMBL FFRENLAFPQGEAREFSPEQTRTNSPRTHSPTSRELWDGGRSNLPSEAGTEGQGTISSLN FPQITLWQRPLVTVRLGGQLIEALLDTGADDTVLEEIDLPGRWKPKMIGGIGGFIKVRQY DQIPIEICGKKAIGTVLVGPTPINIIGRNMLTQIGCTLNFPISPIETVPVKLKPGMDGPK VKQWPLTEEKIKALVEICAEMEKEGKISKIGPENPYNTPVFAIRKKDSTKWRKLVDFREL NKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETP GIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRT KIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKL VGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYD PSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESI VIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETF YVDGAANRETKLGKAGYVTNRGRQKVVTLTDTTNQKTELQAIYLALQDSGLEVNIVTDSQ YALGIIQAQPDQSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVL FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGI WQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSN FTSATVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAV FIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAK LLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED